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ABSTRACT 
 
Calcium signaling affects almost every aspect of cell biology, from fertilization of the egg cell to 
growth and differentiation of all cell types. The transient receptor potential canonical (TRPC) 
channels are calcium permeable cation channels that are activated downstream of G-protein 
coupled receptors through various mechanisms. Effects for TRPCs in regulation of proliferation 
and cell movement have been reported. Based on this, the TRPCs might have potential roles in 
diseases.   
The results presented here show novel functions for TRPC2 and TRPC3. Overexpression of 
TRPC3 revealed a possible role for this channel as an intracellular calcium release channel in 
the endoplasmic reticulum. In contrast to some reports, TRPC3 was not involved in store-
operated calcium entry. However, TRPC3 was activated directly by a diacylglycerol-analog, 
which implies that the channel is putatively involved in receptor-operated calcium entry. 
TRPC2 has important functions in regulating pheromone-sensing and social behavior in 
mice. Here we show that TRPC2 is involved in autocrine sphingosine-1-phosphate (S1P) 
signaling. S1P produced in the cells by sphingosine kinase 1 was transported to the 
extracellular space where it activated S1P2-receptors and calcium entry through a calcium 
channel. Results indicate that TRPC2 most likely was responsible for this calcium entry. 
Moreover, TRPC2 was found to have important downstream effects in a thyroid cell model. 
TRPC2 negatively regulates cAMP production in the cells, which suppress the extracellular 
signal-regulated kinase (ERK) pathway. When TRPC2 expression is reduced the activity of the 
cAMP/ERK pathway is enhanced, which increased the expression of thyroid-stimulating 
hormone receptor (TSHR). We speculate that the cAMP pathway might regulate TRPC2 by 
activation of protein kinase A. Taken together, TRPC2 and the cAMP pathway seem to cross-
communicate to keep the expression of the TSHR at an appropriate level. Lastly, we provide 
evidence for the importance of TRPC2 in regulating glycosylation and secretion of the 
precursor to thyroid hormones.    
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1 INTRODUCTION 
 
Calcium signaling is involved in almost every major decision that cells make. Calcium ions use a 
wide array of different effectors to control everything from the fertilization of an egg cell to 
the growth and differentiation of all types of cells. With the fate of cells tightly intertwined 
with the regulation of calcium fluxes, it is not surprising that deregulated calcium signaling is 
involved in many diseases.  
There are two major pools of calcium ions in multicellular organisms, a major extracellular 
and a minor intracellular pool. Calcium channels are gateways for extracellular calcium ions to 
enter cells where they bind to calcium-binding proteins that translate increased calcium levels 
to cellular effects. One class of channels that mediate calcium entry is transient receptor 
potential canonical (TRPC) channels. They are activated by a multitude of different stimuli, 
however, a unifying factor is that they are activated downstream of G-protein coupled 
receptors (GPCRs). The importance of the localization of these channels has been emphasized 
in many studies and misdirected proteins might explain differences reported.  
Several sphingolipids have important cell signaling properties, while others have structural 
roles. Sphingosine-1-phosphate (S1P) functions as a mitogen and activation of its plasma 
membrane receptors have important effects on cell signaling, including calcium signaling.   
The research presented herein, attempts to elucidate new functions and regulation 
mechanisms for TRPC2 and TRPC3. The importance of TRPC3 has previously been investigated 
in many different systems. Conflicting evidence regarding activation mechanisms for TRPC3 
have been reported. By studying how TRPC3 functions in an overexpression system, I describe 
why peculiarly the intracellular calcium stores are negatively affected. TRPC2 has been studied 
extensively in mouse models, where the channel is important for pheromone recognition and 
social behavior. Furthermore, TRPC2, like TRPC3, seems to be activated downstream of GPCR-
activation. In this thesis, the mechanism by how the bioactive lipid sphingosine-1-phosphate 
(S1P) augments calcium entry by an autocrine mechanism through a S1P-receptor is described. 
In addition, initial evidence for TRPC2 mediating the calcium entry regulated by S1P is 
presented. Lastly, I show evidence for the importance of TRPC2 in thyroid cells. The results 
show that TRPC2 regulates the cAMP pathway and subsequently the extracellular signal-
regulated kinase 1/2 (ERK1/2), which controls the expression of the thyroid-stimulating 
hormone receptor. Moreover, TRPC2 might have a role in regulating thyroid hormone 
production and secretion. 
Taken together, this thesis presents novel insights into how TRPC2 and TRPC3 channels 
regulate and influence calcium homeostasis in eukaryotic cells. For TRPC2, the influence of 
calcium signaling on downstream effects in a thyroid cell model was investigated.          
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2 REVIEW OF THE LITERATURE 
 
2.1 Calcium signaling 
 
The field of calcium signaling has made tremendous strides since Sidney Ringer’s pioneering 
work on the importance of calcium for the contraction of frog hearts in the 1880s  (Ringer, 
1883). It took decades until the findings of Ringer would be understood on a molecular level 
(Katz, 2001). Nonetheless, it is remarkable how an experiment mistakenly made with 
contaminated tap water, instead of distilled water, would start a research field that we today 
call calcium signaling. 
Another great advance in calcium signaling was made when Michael Berridge, working 
with fluid secretion from insect salivary glands, showed that inositol phosphates were involved 
in releasing calcium ions from intracellular calcium stores (Berridge, 2005). In a now classic 
Nature paper from 1983, Berridge and coworkers eventually showed that it was inositol 1,4,5-
trisphosphate (IP3) that releases calcium from intracellular stores (Streb et al., 1983). 
The intracellular calcium stores are limited in comparison to the almost unlimited pool of 
extracellular calcium ions. Extracellular calcium can enter cells through three classes of 
calcium channels, i.e. voltage-operated channels (VOCs), receptor-operated channels (ROCs), 
and store-operated channels (SOCs) (Berridge, 1997).   
How does the simple calcium ion assert its effects on cellular functions? To answer this 
question, one has to look at how proteins are regulated. The functions of proteins are 
regulated by their shape and charge. When calcium binds to specific sites on calcium-binding 
proteins it changes both their charge and shape, and thus regulates their function (Clapham, 
2007). There are three classes of proteins that bind calcium ions and thus work as calcium 
effector proteins; they are proteins that contain an EF-hand domain (Nakayama and 
Kretsinger, 1994) or a C2 domain (Lemmon, 2008), and a third class of proteins called annexins 
(Gerke et al., 2005).  
Calcium ions are mobilized from both intra- and extracellular stores, after which they 
regulate downstream effectors proteins. Thereafter, the calcium signal must be terminated 
and intracellular calcium concentrations are lowered (Figure 1). Typical resting calcium ion 
concentrations in eukaryotic cells are ~100 nM, but they may transiently increase up to 
20,000-fold, into the mM range. A calcium ion concentration this high is highly toxic for cells 
and must be lowered quickly. As calcium ions cannot be broken down, they must be 
compartmentalized and buffered or extruded from the cells (Clapham, 2007). Calcium is 
removed from the cytoplasm by various pumps and exchangers. The sarco-endoplasmic 
reticulum ATPase (SERCA) pumps calcium into the endoplasmic reticulum (ER), where it is 
sequestered by calcium binding proteins and kept in storage awaiting the next stimulus. 
Calcium is also transported out of the cell by plasma membrane calcium ATPase (PMCA) and 
the sodium/calcium exchanger (NCX) (Berridge et al., 2000; Berridge et al., 2003). Also 
mitochondria have important functions in modulating calcium signals. The mitochondrial 
calcium uniporter serves to take up calcium into mitochondria and thus lowers cytosolic 
calcium levels (Walsh et al., 2009). Also Golgi organelles can apparently sequester calcium by 
uptake mediated by the secretory-pathway calcium ATPases (SPCAs) (Berridge et al., 2003). 
Review of the Literature 
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Calcium signaling is crucial for many key events in the life cycle of eukaryotic cells. They 
include fertilization of the egg cell (Machaca, 2011), gene transcription (Alonso and Garcia-
Sancho, 2011), secretion of proteins (Hay, 2007), movement (Prevarskaya et al., 2011), 
proliferation (Roderick and Cook, 2008), and finally the death of the cell (Decuypere et al., 
2011). With a signaling repertoire such as this, it comes as no surprise that deregulated 
calcium signaling could be involved in the development and progression of diseases. In the 
chapters to come, relevant literature for understanding general calcium signaling is reviewed. 
In addition, the cAMP and ERK1/2 pathways will be discussed. 
 
 
 
 
 
 
Figure 1. The general effectors that shape the calcium signal in cells. A G-protein coupled 
receptor is depicted; however, this schematic is the same for any receptor that couples to 
phospholipase C (PLC). Following activation of PLC, diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate (IP3) are produced. IP3 activates its receptor (IP3R) on the ER, which results in 
calcium release from the ER into the cytosol. Furthermore, DAG is able to activate transient 
receptor potential canonical (TRPC) channels in the plasma membrane, which allow calcium 
ions to enter the cell. Activation of IP3Rs will lower the concentration of calcium ions in the ER; 
this is sensed by stromal interaction molecule 1 (STIM1). STIM1 oligomerizes and activates 
store-operated calcium entry through Orai1 channels in the plasma membrane. Excitable cells 
have voltage-operated calcium channels (VOCs); these channels are activated by 
depolarization of the plasma membrane. Calcium entry through VOCs is amplified by calcium 
release from the ER through ryanodine receptors (RyRs), which are activated by calcium. 
When the calcium concentration is at peak level, calcium pumps and exchangers start to lower 
the intracellular free calcium concentration. The SERCA uses energy stored in ATP to pump 
calcium into the ER, whereas the plasma membrane calcium ATPase (PMCA) pumps calcium 
out of the cell. Moreover, secretory pathway calcium ATPase (SPCA) transports calcium ions 
into the Golgi apparatus. The sodium calcium exchanger (NCX) removes one calcium ion for 
every three sodium ions that flows down the electrochemical gradient. 
Review of the Literature 
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2.1.1 Calcium release  
There are a few known second messengers that have well documented effects on calcium 
mobilization from intracellular stores. However, since cyclic adenosine diphosphate ribose- 
and nicotinic acid dinucleotide phosphate-mediated release of calcium are not relevant for the 
understanding of the findings presented here, they will not be discussed further. There are 
also some reports of intracellular calcium release mediated by sphingosine-1-phosphate (S1P). 
At present, there is no known intracellular receptor for S1P that would mediate calcium 
release. For this reason, the focus is on explaining calcium release mediated by IP3. 
   
2.1.1.1 Activation of phospholipase C and the production of IP3 
Activation of phospholipase C (PLC) generates the main intracellular calcium releasing agent, 
IP3. PLC produces two important secondary messengers by hydrolyzing phosphatidylinositol 
4,5-bisphosphate (PIP2) to IP3 and diacylglycerol (DAG). IP3 releases calcium from intracellular 
stores by activating IP3-receptors (IP3R) on the ER membrane, while DAG activates protein 
kinase C (PKC) and also activates some TRPC channels (Berridge et al., 2003). 
There are six classes of PLC isoforms that are grouped together based on sequence 
similarities. All classes contain several members and even more variants can be formed 
through alternative splicing. Almost all PLC isoforms have four conserved domains; the 
catalytic domain, a pleckstrin homology (PH) domain for PIP2 binding, and both EF-hands and a 
C2 domain for calcium binding (Katan, 2005). Emphasis will be put on explaining how the GPCR 
signaling pathway controls IP3-production, as it is more relevant for this study.  
PLC beta (β) is activated by many G-protein coupled receptors (GPCRs). When the receptor 
is activated, it catalyzes the exchange of GDP for GTP on the α-subunit of the G-protein 
heterotrimer. Once in a GTP-bound state, the α-subunit dissociates from the βγ-subunits and 
both the α- and the βγ-subunits are free to activate PLCβ (Rebecchi and Pentyala, 2000). PLCβ 
is mainly activated by αq/11-family G-protein subunits (Smrcka et al., 1991), with different 
members of the Gαq/11-family activating different PLCβ-isoforms to a various degrees (Lee et 
al., 1992). In addition to this pertussis toxin-insensitive pathway, there is also a pertussis toxin-
sensitive pathway to activate PLCβ. αi/o-type G-protein subunits, which are inhibited by 
pertussis toxin, activate PLCβ (Moriarty et al., 1990). In addition, βγ-subunits of Gαi/o-type G-
proteins can also activate PLCβ by binding to a different site than the Gα-subunits (Smrcka and 
Sternweis, 1993). There are many levels of cross-communication between the cAMP and 
calcium pathways, also on the level of IP3-production. Evidence for protein kinase A (PKA) -
mediated inhibition of PLCβ2 (Liu and Simon, 1996) and PLCβ3 (Ali et al., 1997) has been 
reported. Phosphorylation of PLCβ2 was found to inhibit Gβγ-mediated activation, while 
phosphorylation of PLCβ3 inhibited its activation by a Gi/o-coupled receptor.  
PLC gamma (γ) is activated by receptor tyrosine kinases (RTKs). In order to interact with 
RTKs, PLCγ has an additional PH domain, two Src homology (SH) 2 domains and a SH3 domain 
(Katan, 2005). PLC delta (δ) is activated by the atypical G-protein, Gh. PLCδ is also activated by 
calcium concentrations in the µM range, which indicates that it could function as an amplifier 
of the calcium signal initiated by other PLCs (Rebecchi and Pentyala, 2000).  PLC zeta (ζ) is a 
sperm-specific PLC-isoform that is important for fertilization and induces calcium oscillations 
in the egg (Saunders et al., 2002). PLC epsilon (ε) has a unique mode of regulation, as it is 
regulated by small GTPases of the Ras superfamily. In addition to the conserved domains, PLCε 
contains a Cdc25 domain that has guanyl-nucleotide exchange factor activity and two Ras 
Review of the Literature 
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association (RA) domains (Bunney and Katan, 2006). PLC eta (η) is the newest class, which has 
two members. At least PLCη2 is, like PLCβ, activated by Gβγ-subunits downstream of GPCR 
activation (Zhou et al., 2005). 
After IP3 has been formed by the action of PLCs, IP3 is free to activate its receptor, the IP3R, 
on the ER membrane. Mammals, and all other vertebrates, have three types of IP3Rs that are 
ubiquitously expressed and are primarily located on the ER membrane (Foskett et al., 2007). 
The IP3Rs form a massive homo- or heterotetramer complexes, which are mainly regulated by 
calcium. Gating of the channel is activated at low and inhibited at high calcium concentrations. 
IP3-binding to the IP3R removes the inhibitory action of calcium and enables calcium to bind to 
activating sites on the receptor (Mak et al., 1998). Activation of one IP3R and the release of 
calcium can in turn activate another IP3R; this feed-forward mechanism is called calcium-
induced calcium release (Berridge, 1997). Regulation of the IP3R is complex and there are 
multiple interacting proteins and kinases affecting its activity (Foskett et al., 2007). One rather 
well defined regulator of the IP3R1 is PKA. There are two phosphorylation sites for PKA on 
IP3R1 at serine 1589 and serine 1755 (Ferris et al., 1991). When these residues are 
phosphorylated, calcium release by IP3R1 is potentiated (Wagner et al., 2004). Second 
messenger molecules are usually rapidly broken down in cells. The enzymes responsible for IP3 
breakdown or modulation are inositol polyphosphate 5-phosphatases and IP3 3-kinase, 
respectively. The former will produce an inactive inositol phosphate that ultimately is stripped 
down to free inositol. IP3 3-kinase phosphorylates IP3 to form an inositol phosphate with other 
potential signaling properties (Pattni and Banting, 2004).  
 
2.1.2 Calcium entry 
 
There are three groups of plasma membrane calcium channels. They are grouped according to 
their activation mechanism into VOCs, SOCs and ROCs (Berridge, 1997). Emphasis is here put 
on explaining calcium entry mediated by ROCs, as TRPC channels are important conveyors of 
receptor-operated calcium entry. 
 
2.1.2.1 Voltage-operated calcium entry 
Voltage-operated or voltage-gated calcium channels are, as the name implies, activated by a 
change in membrane potential. They are rapidly activated upon membrane depolarization and 
inactivated upon repolarization. There are five types of VOCs that belong either to low voltage 
activated or high voltage activated channels (Tsien and Tsien, 1990). T-type channels are low 
voltage activated and L-, N-, P/Q-, and R-type are high voltage activated. VOCs consist of α1-, 
β- and α2δ-subunits (Catterall, 2000). Calmodulin (CaM) is also considered an essential 
component of VOCs, since CaM also binds VOCs independently of calcium (Halling et al., 2006).  
The α1-subunit forms the voltage-sensing pore and consists of four homologous repeats. Each 
homologous repeat has six transmembrane segments, the first four segments convey voltage-
sensing, while the two last form the calcium-selective pore (Van Petegem and Minor, 2006). 
VOCs are inactivated by voltage-dependent inactivation and calcium-dependent inactivation. 
However, VOCs can also be primed for activation by calcium-dependent facilitation (Catterall, 
2000). The β-subunit binds to the first two segments of the α1-subunit and affects gating and 
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trafficking of the channel. The α2-subunit is linked to the transmembrane δ-subunit through 
disulfide bonds and it enhances channel function (Tsien and Tsien, 1990; Catterall, 2000).  
 
2.1.2.2 Store-operated calcium entry mediated by STIM1 and Orai1 
The molecular components of store-operated calcium entry (SOCE) were unknown until 2005. 
Stromal interaction molecule 1 (STIM1) was first identified as an essential component of SOCE 
(Roos et al., 2005). Later in the same year, STIM1 and STIM2 were found to be calcium sensors 
in the ER (Liou et al., 2005). Following calcium depletion, STIM1 translocates and forms puncta 
close to the plasma membrane (Liou et al., 2005; Zhang et al., 2005). A mutant form of Orai1 
was discovered as the cause of hereditary severe combined immune deficiency, where the 
patients’ immune cells lack SOCE (Feske et al., 2006). Simultaneously, another group found 
Orai1 to be essential for SOCE in an RNA interference screen (Vig et al., 2006b). SOCE was 
largely unaffected by overexpression of either STIM1 or Orai1. However, SOCE was massively 
increased when STIM1 and Orai1 were overexpressed together (Peinelt et al., 2006; Soboloff 
et al., 2006). It was concluded that STIM1 functions as the calcium sensor in the ER and Orai1 
tetramers function as the pore-forming subunit of SOCs (Prakriya et al., 2006; Vig et al., 2006a; 
Mignen et al., 2008). The N-terminus of STIM1 contains a calcium-binding EF hand and a sterile 
alpha motif, which are two domains necessary for STIM1 to function as ER luminal calcium 
sensor (Stathopulos et al., 2008). STIM1 oligomerizes in response to a drop in ER calcium 
concentration and this is the first step in activating SOCE (Luik et al., 2008). After activation, 
STIM1 tetramers translocate to ER sites close to the plasma membrane and activate SOCE 
through tetramerization of Orai1 (Penna et al., 2008). Gating of Orai1 is regulated by a ~100 
amino acid fragment in STIM1 which was described simultaneously by two groups as STIM1 
Orai activating region (SOAR; amino acids 344-442) (Yuan et al., 2009) or CRAC activation 
domain (CAD; amino acids 342-448) (Park et al., 2009). SOCE is inactivated by calcium-
dependent inactivation, which requires both a short domain C-terminal to the CAD domain in 
STIM1 and CaM binding to Orai1 (Lee et al., 2009; Mullins et al., 2009). In a recent report, 
STIM1 was reported to also regulate the ion selectivity of Orai1 (McNally et al., 2012).  
 
2.1.2.3 Receptor-operated calcium entry mediated by TRPC channels 
The transient receptor potential cation channels are named after the Drosophila mutant, 
whose eyes had a transient response to light (Cosens and Manning, 1969). It took 20 years 
until Drosophila TRP was cloned and its tentative identification as a channel (Montell and 
Rubin, 1989). The TRP superfamily of cation channels consist of seven subfamilies, six of which 
are present in mammals (Montell, 2005). The classical or canonical TRPs, the TRPCs, are the 
closest relatives to the Drosophila TRP channel. Activation of the GPCR-Gq-PLCβ cascade 
results in a transient increase in intracellular calcium. This transient increase is followed by a 
sustained calcium increase which is dependent on extracellular calcium. TRPC channels were 
discovered when the identity of channels responsible for sustained calcium increases were 
investigated (Abramowitz and Birnbaumer, 2009; Birnbaumer, 2009).  
TRPC channels have six transmembrane segments with the pore being located between the 
last two (Figure 2) (Vannier et al., 1998). The N-terminus contains several ankyrin motifs that 
are important for protein-protein interactions. The N-terminus and the ankyrin repeats are 
involved in TRPC subunit tetramerization and are thus critical for channel function (Lepage et 
Review of the Literature 
11 
 
al., 2006; Lepage et al., 2009). The C-terminus contains one or more CaM-binding sites, one or 
more IP3R binding sites, and a PDZ domain. The IP3R- and CaM-binding sites are important for 
activation and inhibition of the channel, respectively (Birnbaumer, 2009). The PDZ domain is, 
like the ankyrin motifs, important for protein-protein interactions (Harteneck, 2003). TRPCs 
also have a highly conserved TRP domain after the channel forming transmembrane domain 
(Venkatachalam and Montell, 2007; Birnbaumer, 2009). 
With a wealth of knowledge on what TRPC channels are important for, it is rather 
surprising that the gating mechanisms are not better characterized (Birnbaumer, 2009). Direct 
activation of TRPCs by DAG is the most studied. TRPC3 and 6, but not TRPC1, 4 and 5, were 
first shown to be activated by DAG-analogs (Hofmann et al., 1999a). The cloning and 
characterization of TRPC7 revealed another DAG-activated TRPC (Okada et al., 1999). TRPC2 is 
also activated by DAG-analogs (Lucas et al., 2003). TRPCs are phosphorylated and inactivated 
by PKC. As DAG also is a potent activator of conventional and novel PKC isoforms, this revealed 
a classical negative-feedback regulatory mechanism (Venkatachalam et al., 2003). Moreover, 
PKC-inhibition prior to stimulation with a DAG-analog revealed that also TRPC4 and 5 are 
activated by DAG (Venkatachalam et al., 2003). In contrast, there are no reports for DAG-
mediated activation of TRPC1 (Birnbaumer, 2009; Albert, 2011). 
PIP2 is not only the precursor to IP3 and DAG, it also possesses signaling properties (Suh 
and Hille, 2005). More often PIP2 has an activating effect on channel function, although, some 
TRP channel members are inhibited by PIP2 (Suh and Hille, 2005; Kukkonen, 2011). As often is 
the case in the TRPC field, conflicting reports regarding the regulatory function of PIP2 on 
channel function have been published. At least in portal vein vascular smooth muscle cells, 
PIP2 has an inhibitory effect on DAG-activated TRPCs (Albert, 2011). Furthermore, TRPC4 was 
shown to be inhibited by PIP2. Interestingly, only the full-length protein was inhibited, and not 
TRPC4β, which lacks 84 amino acids in the C terminus (Otsuguro et al., 2008). In contrast, 
TRPC6 is activated by phosphoinositides, most potently by PIP3 and PIP2 (Kwon et al., 2007). It 
was reported that phosphoinositides compete for the CaM-binding site and thus remove 
channel inhibition (Kwon et al., 2007). This would group at least TRPC6 with other TRP 
channels such as TRPMs, which are activated by PIP2 (Nilius et al., 2006). This is still a matter of 
debate, however; a stimulatory action by DAG and inhibitory action by PIP2 would fit nicely 
with the GPCR-Gq-PLCβ pathway: activation of PLC would remove inhibition and produce the 
agonist for activating the channel. 
Another possible way of activating TRPCs is through conformational coupling with ER 
calcium release channels, mainly IP3Rs (Venkatachalam and Montell, 2007; Birnbaumer, 2009). 
In this model, activation of IP3Rs would subsequently activate TRPCs in the PM. Such 
interactions have been shown for heterologously expressed IP3R and TRPC3 and 6 (Kiselyov et 
al., 1998; Boulay et al., 1999). There is evidence for the involvement of the Homer scaffolding 
proteins in the conformational coupling model (Yuan et al., 2012). Homer1 binds to the N-
terminus of the IP3R and to the C-terminus of TRPCs. It seems that Homer1 keeps TRPCs 
inactive until IP3Rs are activated, where after the IP3R-Homer1-TRPC complex dissociates and 
TRPCs are activated (Yuan et al., 2003). Furthermore, Homer1 has been shown to aid the 
translocation of TRPC3 to the PM (Kim et al., 2006). TRPCs, like many other calcium channels, 
are negatively regulated by CaM. Activation of TRPCs through displacement of CaM by IP3R has 
been reported (Zhang et al., 2001). 
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Figure 2. Schematic picture of TRPC structure. TRPC channels have six transmembrane (TM) 
domains. The pore is located between TM5 and TM6. TRPC channels contain several domains 
that are important for protein interactions and channel regulation, among them the Homer 
binding motif in the TRP domain and the IP3R/CaM binding domain [modified from (Vazquez et 
al., 2004)].  
 
2.1.3 Calcium binding proteins 
The calcium ion needs a sensor that conveys changes in intracellular calcium concentrations 
into cellular responses. There are three main groups of proteins that bind calcium and confer 
calcium-mediated responses; EF-hand proteins, annexins, and C2-domain proteins. 
   
2.1.3.1 EF-hand protein  s
EF-hand proteins are named after the calcium-binding domain formed by helices E and F of 
parvalbumin (Kretsinger and Nockolds, 1973; Gifford et al., 2007). Several well-known calcium-
binding proteins are EF-hand proteins, e.g. CaM, troponin C, and aequorin. The EF-hand 
consists of an α-helix, a loop around the calcium ion, which is followed by a second α-helix 
(Nakayama and Kretsinger, 1994). The calcium binding domain is rich in negatively charged 
amino acids such as aspartic acid and glutamic acid. In most cases it is aspartic acid side chains 
that provide the oxygen ligands to which the calcium ion bind (Gifford et al., 2007). EF-hand 
proteins usually consist of two calcium binding domains, however, some contain three or 
more. The best known EF-hand protein is CaM. CaM has two calcium binding EF-hand domains 
connected with a flexible linker (Bhattacharya et al., 2004). CaM is inactive when not bound to 
calcium and changes conformation when the calcium concentration increases. The 
conformation change enables CaM to interact with downstream effectors (Nakayama and 
Kretsinger, 1994). The conformational change reveals hydrophobic side chains that form the 
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protein interaction domain (Zhang et al., 1995a; Gifford et al., 2007). However, not all EF-hand 
proteins are important for signaling. For example, parvalbumin chelates calcium and thus 
functions as a calcium buffer and prevents the cytotoxic effects of high calcium concentrations 
(Gifford et al., 2007).  
 
2.1.3.2 Annexins 
Annexins are another class of calcium-binding proteins. The annexins are curved disc-shaped 
proteins, which in a calcium-dependent manner are able to interact with cellular membranes 
with their convex surface (Huber et al., 1990; Gerke et al., 2005). The annexin core is 
comprised of ~310 amino acids and contains four annexin repeats. One annexin repeat is 
made of five α-helices with calcium-binding loops separating them (Lemmon, 2008). Calcium 
binding to calcium binding sites on this outer convex surface gives rise to a conformational 
change in the annexins. This conformational change reveals carbonyl and carboxyl groups that 
are able to interact with phosphoryl moieties of the phospholipids in the cell membrane 
(Gerke et al., 2005). The concave surface faces the cytoplasm and functions as a docking site 
for other proteins. Calcium-bound annexin A5 has been shown to interact with membranes 
through insertion of a tryptophan residue into the membrane (Concha et al., 1993). The N-
terminus on the concave surface houses domains to which several EF-hand proteins bind. The 
N-terminus is also subject to post-translational modifications. Phosphorylation of tyrosine 
residues modulates the calcium and membrane binding of annexins A1 and A2. EGF receptor 
kinase and Src kinase phosphorylate tyrosine residue 20 in annexin A1 and tyrosine residue 23 
in annexin A2, respectively (Gerke and Moss, 2002). Furthermore, phosphorylation of annexins 
by serine/threonine kinases has been reported. For example, phosphorylation of annexin A2 
by PKC is essential for calcium-regulated exocytosis (Sarafian et al., 1991; Gerke and Moss, 
2002). Annexins are also involved in changing membrane curvature and cell shape by 
modulating actin rearrangement (Gerke et al., 2005). Furthermore, evidence for annexins 
regulating calcium fluxes has also been shown (Gerke and Moss, 2002). 
 
2.1.3.3 C2-domain proteins 
The third class of calcium-binding proteins, C2-domain proteins, share functional 
characteristics with annexins but are structurally different (Lemmon, 2008). The C2-domain 
was first studied in conventional PKCs and is therefore named after the second homology 
region in PKC (Cho and Stahelin, 2006; Lemmon, 2008). The ~130 amino acid C2-domain 
contains eight antiparallel β-strands with three loops that connect the β-strands. The inter-
strand loops are responsible for binding calcium ions and membrane lipids (Cho and Stahelin, 
2006; Lemmon, 2008).  The general consensus is that, upon calcium binding to the C2 domain, 
the protein translocates to cellular membranes and binds phosphatidylserine. However, many 
C2-domains bind calcium with low affinity and some C2-domain proteins function 
independently of calcium (Cho and Stahelin, 2006). Studies have shown that calcium changes 
the electrostatic potential of the C2-domain and thus favors binding to negatively charged 
membranes (Shao et al., 1997; Lemmon, 2008). Furthermore, calcium ions seem to function as 
bridges between the C2-domain and the anionic phospholipids (Ubach et al., 1998; Lemmon, 
2008). There is also evidence that calcium-mediated conformational changes could trigger C2-
domain interactions with the plasma membrane (Sutton et al., 1995). 
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Lipid selectivity varies between different C2-domains. The C2-domains in conventional 
PKCs bind phosphatidylserine with high affinity. However, other C2-domains bind all 
negatively charged phospholipids, while some prefer zwitterionic phospholipids (Cho and 
Stahelin, 2006; Lemmon, 2008). 
 
2.1.4 Decreasing intracellular calcium 
The primary task of calcium pumps (ATPases) and exchangers is to lower intracellular calcium 
to avoid the toxic effects of high calcium concentrations. However, the pumps and exchangers 
also affect the amplitude and duration of the calcium signal. After the rapid increase of 
intracellular calcium that follows upon e.g. activation of a GPCR, SERCA tries to replenish the 
intracellular stores in the ER and PMCA and NCX function to lower intracellular calcium levels 
by extruding calcium.  
 
2.1.4.1 P-type calcium ATPases 
Three classes of calcium pumps (P-type calcium ATPases) are expressed in membranes of 
mammalian cells. The SERCA is located mainly in the ER, the SPCA in the Golgi, and PMCA in 
the plasma membrane. As the name foretells, P-type calcium ATPases hydrolyze ATP to pump 
calcium ions against their electrochemical gradient. P-type ATPases exist transiently as a 
phosphorylated intermediate, after which they are named (Pedersen, 2007; Brini and Carafoli, 
2009). The P-type ATPase superfamily has eight subfamilies and hundreds of members (Brini 
and Carafoli, 2009). The P-type ATPases have high affinity for calcium on the cytoplasmic side. 
When calcium binds, a series of conformational changes take place, which favors 
phosphorylation of a catalytic residue. The phosphorylated form has lower affinity for calcium 
and calcium is released in the ER or outside of the cell. Thereafter, the phosphate group is 
hydrolyzed and the high affinity form is regenerated (Brini and Carafoli, 2009). SERCA has two 
calcium-binding sites in the transmembrane helices, while PMCA and SPCA only have one. 
Both PMCA and SPCA lack an essential acidic residue in transmembrane domain 5, which 
explains why these two only transport one calcium ion for every ATP hydrolyzed (Clarke et al., 
1989; Clarke et al., 1990; Brini and Carafoli, 2009).  
Mammals have three SERCA genes. Their transcripts undergo tissue-specific alternative 
splicing which increases the number of isoforms. SERCA1a and 1b are expressed in fast-twitch 
skeletal muscle cells. SERCA2a is expressed in the heart and in slow-twitch muscle cells. 
SERCA2b is considered a housekeeping isoform and is ubiquitously expressed. The SERCA3 
isoforms are not that well known, however, they seem specialized for relaxation of vascular 
and tracheal smooth muscle cells (Brini and Carafoli, 2009). The activity of SERCA1a, SERCA2a, 
and SERCA2b are regulated by phospholamban (James et al., 1989; Fujii et al., 1990). The 
inhibitory action of phospholamban is reversed if phospholamban is phosphorylated by PKA 
(Tada et al., 1979; Toyofuku et al., 1993) or CaM kinase II (CaMKII) (Mattiazzi et al., 1998; 
Kuschel et al., 1999; Brini and Carafoli, 2009). In a recent study, sumoylation was found to 
stabilize and increase the activity of SERCA2a (Kho et al., 2011). 
The SPCA is the newest member of the calcium ATPases. Two human SPCA isoforms have 
been described (Hu et al., 2000; Xiang et al., 2005; Brini and Carafoli, 2009): SPCA1 is 
ubiquitously expressed while SPCA2 expression is more restricted (Brini and Carafoli, 2009). 
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Interestingly, the SPCAs are also efficient transporters of manganese (Van Baelen et al., 2001). 
There are several enzymes in the Golgi lumen that require manganese as a co-factor, which 
could explain why SPCAs have evolved this function (Brini and Carafoli, 2009).   
There are four isoforms of PMCAs and numerous splice variants. PMCA1 and 4 are 
ubiquitously expressed. PMCA2 and PMCA3 are mainly expressed in the nervous system and 
muscle cells (Strehler and Zacharias, 2001). PMCAs have high calcium affinity but low transport 
capacity, and are thus minor regulators of intracellular calcium concentrations (Brini and 
Carafoli, 2009). The PMCAs are inhibited in the absence of CaM, when the C-terminal tail binds 
two intracellular loops and inhibits activity. When the calcium concentration rises, calcium-
CaM binds a domain in the C-terminal. This induces a conformational change that frees the 
catalytic domain (Strehler et al., 2007). PMCA is phosphorylated in the C-terminal by PKA 
(Neyses et al., 1985) or PKC (Wang et al., 1991). This has been reported to facilitate PMCA 
activity (Strehler et al., 2007). The 14-3-3ε protein, on the other hand, has an inhibitory effect 
on pump activity when it interacts with the N-terminal of PMCA4 (Rimessi et al., 2005).  
 
2.1.4.2 Sodium/calcium exchanger 
When it comes to removing calcium from the cytosol, the low-affinity high capacity NCX 
complements the high-affinity low capacity PMCAs very well (Clapham, 2007). The NCX can 
move calcium into or out of cells depending on the electrochemical driving force (Blaustein 
and Lederer, 1999). In the forward mode of action, one calcium ion is extruded for every three 
sodium ions that flow along the electrochemical gradient (Hilgemann et al., 1991). Three 
isoforms of NCX have been cloned, but additional isoforms are made through alternative 
splicing (Guerini et al., 2005). The NCX1 isoform is ubiquitously expressed while NCX2 and 
NCX3 are mostly expressed in excitable cells (Blaustein and Lederer, 1999). The NCXs are 
activated by high intracellular calcium, with a central cytosolic loop being critical for calcium-
mediated activation (Levitsky et al., 1994; Matsuoka et al., 1995). A high intracellular sodium 
concentration, on the other hand, has been reported to inhibit the NCX (Hilgemann et al., 
1992). Although there are reports of phosphorylation-mediated regulation of NCX activity, it is 
still a matter of debate (Lytton, 2007). 
 
2.1.5 Calcium signaling and cancer 
With the aforementioned review on how intracellular calcium concentrations are regulated, 
the end of the chapter will be dedicated to discussing potential implications of rogue calcium 
signaling in cancer.  
Calcium is needed at many stages of the cell cycle and for the movement of cells; 
deregulated calcium signaling is therefore of interest in cancer (Cook and Lockyer, 2006; 
Parkash and Asotra, 2010; Prevarskaya et al., 2011). Intracellular calcium concentrations are 
tightly regulated. Calcium is kept low during the early G1-phase and S-phase, but it rises at the 
G1/S transition and in the G2-phase (Pande et al., 1996). In addition, calcium is needed for 
phosphorylation of the master regulator of the cell cycle, the retinoblastoma protein (Takuwa 
et al., 1993). Calcium-CaM has many important effects on cell proliferation. CaMK regulates 
cyclin D1 expression, which is important for cyclin-dependent kinase (CDK) 4 and CDK2. 
Moreover, Calcium-CaM regulates calcineurin which dephosphorylates and thus activates 
nuclear factor of activated T-cells (NFAT) (Parkash and Asotra, 2010). Calcium influx through 
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the SOC channel Orai1 is important for activation of NFAT (Feske et al., 2006). Which 
transcription factors are activated is largely dependent on the amplitude and duration of the 
calcium signal. In B lymphocytes, NFAT is activated by a low amplitude sustained calcium 
signal, while nuclear factor κB and c-Jun N-terminal kinase require a large transient increase in 
calcium to be activated (Dolmetsch et al., 1997). The TRP channel TRPV6 has been implicated 
in prostate cancer. TRPV6 is overexpressed in prostate cancer and is connected with increased 
NFAT activation and cell survival (Lehen'kyi et al., 2007). Moreover, TRPV6 expression 
correlates with the aggressivity of the cancer, thus making it an interesting target (Fixemer et 
al., 2003). Alterations in calcium pumps have also been investigated in relation to cancer 
susceptibility. Mutations in SERCA2 have been reported to associate with colon and lung 
cancer (Korosec et al., 2006). Downregulation of SERCA2b and resistance to apoptosis was 
seen in neuroendocrine-differentiated prostate cancer cells (Vanoverberghe et al., 2004). 
Reduced calcium uptake to the ER will affect calcium transients negatively; however, it may 
confer resistance to cell death. Reduced IP3-mediated release of calcium from the ER protects 
cells from apoptosis (Szado et al., 2008). Also reports exist for the involvement of PMCA in 
cancer. The expression of PMCA was increased in gastric and colon cancer (Ribiczey et al., 
2007). Moreover, a mutation in PMCA3 has been found in pancreatic cancer cells (Jones et al., 
2008; Brini and Carafoli, 2009). 
The migration of cells requires calcium and the involvement of calcium channels in 
metastatic behavior have gathered interest (Prevarskaya et al., 2011). When cells move, the 
intracellular calcium concentration is lowest at the leading edge of the cell and highest at the 
rear of the cell (Brundage et al., 1991; Hahn et al., 1992). This polarization of calcium is 
thought to facilitate rear-end retraction (Prevarskaya et al., 2011). The internalization and 
recycling of integrins at the rear end of a cell is needed for the cell to move forward. This is 
process is regulated by the calcium-CaM-activated protein phosphatase calcineurin (Lawson 
and Maxfield, 1995).  Focal adhesion kinase is an important regulator of cell migration, which 
calcium can activate through CaMKII (Fan et al., 2005). STIM1 and Orai1 are important for 
focal adhesion turnover and thus migration of breast cancer cells in vitro. Furthermore, RNA 
interference of either STIM1 or Orai1 inhibited metastasis in a mouse model (Yang et al., 
2009). Members of the TRP channels are frequently reported as crucial for cell migration (Lee 
et al., 2011; Prevarskaya et al., 2011). Interestingly, TRPC5 and 6 have been reported to 
activate and inhibit cell migration, respectively. TRPC5 activated the small GTPase Rac1 and 
TRPC6 the small GTPase RhoA, which had diametrically different effects on cell migration (Tian 
et al., 2010). 
 
2.2 GPCR signaling 
 
GPCRs are a large group of plasma membrane receptors with over 800 members. Many key 
physiological functions are controlled by GPCRs; among them are neurotransmission, hormone 
release from endocrine glands, and cardiac contraction. There are three families of GPCRs, 
which are grouped together based on sequence similarities. The sequences vary between 
families to a great extent, but they all share the seven transmembrane domain structure. 
GPCRs convey information to intracellular effectors through G-proteins. The G-proteins are 
heterotrimeric and are comprised of α- and βγ-subunits. The α-subunit binds GTP and GDP and 
has intrinsic GTPase activity. However, a GTPase activating protein (GAP), regulator of G-
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protein signaling, accelerates the hydrolysis of GTP. The β and γ subunits form a tightly bound 
complex. There are at least 16 α, five β, and 12 γ subunits. There are four subfamilies of α-
subunits: αs, αi/0, αq, and α12/13. G-proteins are named on the basis of their α-subunit. For 
example, a heterotrimeric G-protein containing αs is a Gs-protein. To simplify greatly, Gs-
proteins activate adenylyl cyclases (ACs), Gi/0-proteins couple to inhibition of ACs, Gq-proteins 
couple to activation of PLCβ, and G11/12-proteins activate guanine-nucleotide exchange factor 
(GEF) for Rho. When a ligand is bound to the GPCR, it induces a conformational change that 
enables the receptor to interact with its cognate G-protein and promotes GDP dissociation and 
GTP binding. The GTP-bound α-subunit dissociates from the βγ-subunit and activates 
downstream effectors. In addition, there is also evidence that the βγ-subunit activates 
effectors (Neves et al., 2002; Pierce et al., 2002).   
 
2.2.1 Sphingolipid signaling 
S1P, sphingosine, and ceramide are three sphingolipids with well-documented effects on cell 
signaling. Ceramide is a central molecule in sphingolipid biosynthesis and sphingosine is a 
direct breakdown product of ceramide; its formation is catalyzed by ceramidase (Figure 3). The 
phosphorylation of sphingosine and hence the production of S1P is catalyzed by sphingosine 
kinase (SK). All steps are reversible and S1P can be dephosphorylated by S1P phosphatase, and 
ceramide can be re-synthesized from sphingosine by the action of ceramide synthase. 
However, S1P lyase irreversible degrades S1P to hexadecenal and phosphoethanolamine 
(Pitson, 2011). Ceramide synthesis increases in cells in response to many cytotoxic treatments 
and is thus linked to apoptosis. Similarly, sphingosine is a PKC inhibitor and inhibits cell growth 
and induces apoptosis. In contrast, S1P inhibits apoptosis and promotes cell survival. It has 
been proposed that the balance between these three lipids determines the fate of the cell 
(Maceyka et al., 2002). 
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Figure 3. Sphingolipid metabolism. Ceramide is a central molecule in sphingolipid metabolism. 
Ceramide is made by breakdown of sphingomyelin or by de novo synthesis. Sphingosine is a 
direct breakdown product of ceramide. Sphingosine is phosphorylated by SK to S1P. S1P is 
irreversible broken down by S1P lyase, all other steps in sphingolipid biosynthesis are 
reversible. 
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2.2.1.1 Sphingosine-1-phosphate receptors 
There are five GPCRs, termed S1P1-5, that specifically bind S1P. Depending on the receptor 
isoforms expressed, S1P can regulate a wide array of physiologically important processes. In 
addition, the G-proteins add additional complexity, since several S1P-receptors couple to more 
than one family of G-proteins (Figure 4A). However, S1P1 couples exclusively to Gi-proteins. 
S1P2 and S1P3 are more promiscuous and couple to Gi, Gq, and G12/13. S1P4 is able to couple to 
both Gi and G12/13 (Spiegel and Milstien, 2003; Sanchez and Hla, 2004). The least studied S1P-
receptor, S1P5, has also been shown to couple to Gi/0 and G12 (Malek et al., 2001). Downstream 
effectors activated by S1P1 include: ERK, phosphoinositide 3-kinase (PI3K) and PLC. 
Furthermore, S1P1-activation results in inhibition of cAMP accumulation. ERK and PLC are also 
activated by S1P2 and S1P3. Moreover, Rho is regulated by these receptors (Sanchez and Hla, 
2004; Pyne and Pyne, 2010). The downstream effectors of S1P4 and S1P5 are less well known, 
but there is evidence for S1P4 activating Cdc42 and S1P5 activating c-Jun N-terminal kinase 
(Malek et al., 2001; Kohno et al., 2003).   
        
2.2.1.2 Autocrine/paracrine signaling 
An interesting model of action for S1P is that, S1P produced inside the cell is exported and 
activates S1P-receptors on the same or neighboring cell in an autocrine or paracrine fashion, 
respectively (Figure 4B) (Spiegel and Milstien, 2003; Rosen and Goetzl, 2005; Pyne and Pyne, 
2010). Johnson and colleagues were the first to show that SK1 was translocated to the plasma 
membrane via a PKC-dependent mechanism and that the S1P produced was secreted (Johnson 
et al., 2002b). The involvement of ATP binding cassette (ABC) transporters has been implicated 
in the export of S1P in mast cells. Downregulation of ABCC1 in mast cells reduced S1P 
secretion and migration (Mitra et al., 2006). Another ABC transporter, namely ABCA1, 
transports S1P in astrocytes (Sato et al., 2007). This inside-out signaling for S1P is important 
also in cancer cells. In addition to ABCC1, ABCG2 was shown as critical for the release of S1P 
from breast cancer cells in response to estradiol (Takabe et al., 2010). Interestingly, it was 
reported that SPNS2 is important for embryogenesis in zebrafish. A mutation in this gene 
caused the development of two hearts, which is the same phenotype as seen in S1P2-mutants. 
The authors linked SPNS2 to the secretion of S1P and the migration of myocardial precursor 
cells (Kawahara et al., 2009). Moreover, SPNS2 is involved in transport of several S1P-analogs 
in human cells, among them the S1P-receptor agonist FTY720 (Hisano et al., 2011). In contrast, 
there were no changes in plasma S1P concentrations between wild-type and ABCC1 or ABCA1 
knockout mice (Lee et al., 2007). However, it is not known whether ABC transporters have 
overlapping functions or whether some compensatory mechanism was involved (Pyne and 
Pyne, 2010). 
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Figure 4. S1P signaling mediated by S1P-receptors. (A) There are five GPCRs that are 
specifically activated by S1P. S1P1 only couples to Gi-proteins, whereas the other receptors 
couple to two or three classes of G-proteins. A sample of downstream effectors that are 
activated or inhibited by S1P-receptors are depicted. These pathways give rise to a multitude 
of different cellular responses [modified from (Spiegel and Milstien, 2003)]. (B) S1P produced 
inside the cell can be transported out where it activates S1P-receptors through autocrine 
signaling.   
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2.2.2 Thyroid-stimulating hormone receptor signaling 
Thyroid-stimulating hormone (TSH) is a ~30-kDa glycoprotein secreted by the anterior pituitary 
in response to thyrotropin-releasing hormone (TRH) from the hypothalamus. Like all cysteine-
knot growth factors, TSH is comprised of a common α-subunit and a hormone-specific β-
subunit. TSH is a glycosylated protein with human β-subunits having one and human α-
subunits having two carbohydrate chains linked to asparagine residues, respectively. In 
addition to giving species-specificity, the carbohydrate chains seem to improve stability and 
receptor binding (Szkudlinski et al., 2002). TSH controls thyroid hormone production and 
thyroid growth through its G-protein coupled receptor, the TSH receptor (TSHR). Like all 
GPCRs, the TSHR has a C-terminal tail domain, an N-terminal extracellular domain, and seven 
transmembrane domains connected by intra- and extracellular loops (Kleinau and Krause, 
2009). The large N-terminal extracellular domain is sufficient for high-affinity hormone binding 
(Da Costa and Johnstone, 1998). Unlike many closely related GPCRs, the TSHR has a high basal 
activity, which leads to cAMP production in the absence of ligand (Cetani et al., 1996). 
Furthermore, deletions or degradation of parts of the extracellular domain result in receptor 
activation (Zhang et al., 1995b; Van Sande et al., 1996). Point mutations of the TSHR have been 
linked to increased receptor activity and the incidence of thyroid adenomas (Parma et al., 
1993). This is in line with reports showing links between activating mutations in Gαs and 
thyroid adenomas (Lyons et al., 1990). Many thyroid diseases are caused by defective or over-
active TSHR signaling. Hyperthyroidism can result from activating mutations in the TSHR or 
from thyroid-stimulating antibodies acting on the TSHR as an agonist, which is the case in the 
autoimmune disease Graves’ disease (Paschke et al., 1996). If the TSHR loses its ability to 
respond to TSH, the outcome is hypothyroidism. This is the case in a mouse model where a 
point mutation results in loss of function in the TSHR (Stein et al., 1994). The TSHR is subject to 
post-translational modifications, with documented functional effects for glycosylation of 
asparagine residues 77 and 113. Glycosylation of these residues was important for expression 
of functional TSHR at the plasma membrane (Russo et al., 1991). Studies with TSHR-knockout 
mice concluded that the TSHR is important for growth and development and critical for 
thyroid hormone production. Unless supplemented with thyroid hormone the mice died 
within one week of weaning. However, the TSHR is not needed during embryogenesis or for 
thyroid development (Marians et al., 2002; Postiglione et al., 2002). 
Most of the effects mediated by the TSHR are transduced by Gs-proteins (Rivas and 
Santisteban, 2003). However, evidence for the TSHR coupling to Gi/0, Gq, and G12/13 has been 
reported (Laugwitz et al., 1996). However, a relatively high concentration of TSH is required to 
stimulate Gq-proteins (Rivas and Santisteban, 2003).  
 
2.3 cAMP signaling 
 
That cAMP is an intracellular secondary messenger was first discovered in the 1950’s. 
Research in the field of cAMP has resulted in many groundbreaking discoveries (Beavo and 
Brunton, 2002). Many of the effects mediated by the THSR result from activated Gs-proteins 
and AC enzymes, which produce cAMP (Medina and Santisteban, 2000). Peculiarly, cAMP acts 
as a mitogen or anti-mitogen depending on the cell system used. However, thyroid cell 
proliferation is positively regulated by cAMP (Medina and Santisteban, 2000; Rivas and 
Santisteban, 2003).  
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2.3.1 cAMP production by adenylyl cyclases 
The enzymes catalyzing the production of cAMP from ATP are ACs. To date nine ACs have been 
cloned (Sunahara et al., 1996; Cooper, 2003; Willoughby and Cooper, 2007). In addition, one 
soluble AC has been described, and seems to be expressed specifically in the testis (Buck et al., 
1999). The membrane-bound ACs have tissue-specific distribution patterns. However, all nine 
isoforms are expressed in the brain (Hanoune and Defer, 2001). All membrane-bound isoforms 
have two hydrophobic domains, each consisting of six transmembrane domains. Two 
cytoplasmic domains dimerize and form the catalytic site (Cooper, 2003; Willoughby and 
Cooper, 2007). All isoforms are stimulated by Gsα-activation, while all ACs are inhibited by Giα 
except ACs 2, 4 and 7 (Sunahara et al., 1996). There are also reports of ACs being regulated by 
Gβγ-subunits. AC1 and 8 are inhibited, while AC3, 5, 6, and 9 are insensitive to regulation by 
Gβγ (Willoughby and Cooper, 2007).  
The diterpene forskolin, which is extracted from the plant Coleus Forskohlii, is a potent 
activator of all ACs except AC9 (Seamon et al., 1981; Hanoune and Defer, 2001). Forskolin 
binds to the catalytic cleft and promotes assembly of the two cytoplasmic domains, which 
activates the enzyme (Tesmer et al., 1997; Zhang et al., 1997).  
Calcium has well-documented regulatory effects on AC activity (Sunahara et al., 1996; 
Hanoune and Defer, 2001; Cooper, 2003; Willoughby and Cooper, 2007). AC1 and 8 are 
stimulated by calcium by a CaM-dependent mechanism. Mutation of selected residues in the 
CaM-binding domain of AC1 inhibited calcium-stimulated activity (Wu et al., 1993). AC8 has 
two CaM-binding domains, one in the N-terminus and one in the C-terminus. The N-terminal 
domain had little effect on AC8 function when mutated. However, mutation of the C-terminal 
domain decreased calcium-mediated AC8 activity. Interestingly, removal of the domain 
resulted in a hyperactive enzyme. This implies that the C-terminal CaM-domain in AC8 is 
involved in autoinhibition of the enzyme (Gu and Cooper, 1999). Later, it was shown that the 
N-terminal CaM-binding domain is important in recruiting CaM. Furthermore, AC8 binds 
partially calcium-bound CaM, but only fully calcium-bound CaM stimulates the activity of AC8 
(Simpson et al., 2006). In contrast to AC1 and 8, AC5 and 6 activities are inhibited by calcium. 
Interestingly, the mechanism of calcium-mediated inhibition is still largely unresolved and is 
not CaM-dependent (Willoughby and Cooper, 2007). One hypothesis is that calcium ions 
compete with magnesium ions in the catalytic site, the latter being critical for the catalytic 
activity (Guillou et al., 1999). 
Phosphorylation-mediated regulation has been shown for some ACs. The activity of AC5 
and AC6 is reduced by PKA-mediated phosphorylation (Premont et al., 1992; Iwami et al., 
1995; Chen et al., 1997). The PKA phosphorylation site in AC 6, which lies within the catalytic 
domain at serine 674, is responsible for inhibition of activity (Chen et al., 1997). There is also 
evidence for PKC-mediated activation or inhibition of several ACs. However, the significance of 
PKC-mediated phosphorylation of ACs in intact cells remains inconclusive (Willoughby and 
Cooper, 2007). AC3 is the only isoform that has been implicated in direct phosphorylation-
mediated inhibition by CaMKII (Willoughby and Cooper, 2007). Wei and colleagues showed 
that serine 1076 in AC3 was a direct phosphorylation site for CaMKII (Wei et al., 1996). 
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2.3.2 cAMP breakdown by phosphodiesterases 
Phosphodiesterase (PDE) -mediated breakdown of cAMP is the main pathway for reducing 
cellular cAMP concentrations. The cyclic nucleotidase superfamily consists of 11 families of 
PDEs. Dual-specificity PDEs hydrolyze the cyclic phosphate bond in both cAMP and cGMP and 
produce 5’-AMP and 5’-GMP, respectively. PDE1, 2, 3, 10, and 11 belong to this group of PDEs. 
However, PDE4, 7, and 8 are cAMP-specific PDEs, while PDE5, 6, and 9 are cGMP-specific PDEs. 
PDE1-4 are expressed in many tissues, while other cAMP-hydrolyzing PDEs are not widely 
expressed (Francis et al., 2011). The cAMP-specific PDEs will be discussed in more detail 
below. 
Four genes generate the PDE4 family and they are termed PDE4A-PDE4D. More than 20 
members have been described in the PDE4 family and they are produced from these four 
genes by alternative start sites and alternative splicing (Bender and Beavo, 2006). The ability of 
PDE4 isoforms to affect cellular signaling is largely dependent on the localization and 
phosphorylation-regulated activity of the enzyme (Houslay and Adams, 2003; Bender and 
Beavo, 2006). In addition, dimerization is important for the regulation and autoinhibition of 
PDE4 (Francis et al., 2011). The localizations of several PDE4 isoforms have been reported to 
be regulated by different scaffold proteins. PDE4D5 localization is regulated by RACK1 
(Yarwood et al., 1999). PDE4D3 is localized to signaling complexes orchestrated by A-kinase 
anchoring protein (AKAP) (Dodge et al., 2001). Furthermore, β-arrestins have been shown to 
recruit PDE4 isoforms to β2-adrenoceptors. This negative feedback counteracts the cAMP 
formed downstream of the activated β2-adrenoceptor (Perry et al., 2002). Regulatory domains 
and phosphorylation sites are located in the N-terminus. PDE4A has a domain in the N-
terminus that allows the enzyme to bind the membrane lipid phosphatidic acid in a calcium-
dependent manner (Baillie et al., 2002). The activity of PDEs was increased in response to TSH 
and forskolin in FRTL-5 cells. Moreover, it was concluded that the increase in PDE activity was 
a result of PKA-mediated phosphorylation at serine 54 of PDE4D3 (Sette et al., 1994; Sette and 
Conti, 1996). In contrast, an inhibitory effect on PDE4D3 has been reported by ERK2-mediated 
phosphorylation of serine 579 (Hoffmann et al., 1999). PDE4D3 has docking sites for ERK2, 
which are crucial for ERK2 binding and phosphorylation of PDE4D3 (MacKenzie et al., 2000). 
Interestingly, sumoylation of PDE4 was shown to augment activation by PKA and to repress 
inhibition by ERK (Li et al., 2010). 
The PDE7 family has two genes, called PDE7A and PDE7B. Not much is known about the 
regulation and importance of this family of PDEs. It has been hypothesized that PDE7 is 
important for maintaining basal cAMP levels (Bender and Beavo, 2006). PDE7 seems to be of 
importance in immune cells (Smith et al., 2003). Furthermore, inhibition of the PKA pathway 
via PDE7-activation is important for T-cell activation (Li et al., 1999). AKAPs have been shown 
to bind and regulate the translocation of several PDEs (Bender and Beavo, 2006). The AKAP 
myeloid translocation gene translocates PDE7 to the Golgi (Asirvatham et al., 2004). A 
potential role for PDE7B in cancer was shown when increased expression of PDE7B was 
measured in chronic lymphocytic leukemia cells. The authors reported that the increased 
PDE7B expression hampered PKA-dependent apoptosis in these cells (Zhang et al., 2008). 
Like the PDE7 family, the PDE8 family contains two genes termed PDE8A and PDE8B 
(Bender and Beavo, 2006). PDE8 has the highest affinity for cAMP of all PDEs (Gamanuma et 
al., 2003). PDE8 has two regulatory domains (PAS and REC), however, no clear function have 
been described for either of them (Bender and Beavo, 2006). One report shows that PDE8A is 
important for regulating excitation-contraction coupling in the heart (Patrucco et al., 2010). 
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Patrucco and colleagues showed that myocytes from PDE8A knockout mice had lesser calcium 
currents coming through voltage-gated channels than wild-type myocytes. Moreover, the 
importance of PDE8A has been studied in the testosterone-producing Leydig cells of the testis. 
The authors reported that the sensitivity of steroidogenesis for luteinizing hormone was 
increased four-fold in PDE8A knockout mice (Vasta et al., 2006).  
 
2.3.3 Protein kinase A 
PKA is a direct downstream effector of cAMP and one of the most studied serine/threonine 
protein kinases (Pearce et al., 2010). In the inactive state PKA has four subunits, two catalytic 
subunits and two regulatory subunits. When ACs are activated and cAMP is produced, cAMP 
binds to the regulatory subunits and the catalytic subunits are free to phosphorylate 
substrates (Chin et al., 2002; Taylor et al., 2005; Taylor et al., 2008; Pearce et al., 2010).   
There are several isoforms of cAMP-binding regulatory subunits, termed RIα, RIβ, RIIα, and 
RIIβ. However, they all have a similar structure with the same domains but are not functionally 
redundant. In the N-terminus they have a D/D domain that orchestrates dimerization and 
binding to AKAPs. Following the D/D domain is an inhibitor sequence and two cAMP-binding 
domains. The inhibitor sequence functions as pseudosubstrate for the catalytic site in the 
catalytic subunit, thus suppressing activity (Taylor et al., 2005; Taylor et al., 2008).  
There are three isoforms of the catalytic subunits called Cα, Cβ, and Cγ. The major isoforms 
are the Cα and Cβ-isoforms (Taylor et al., 2005; Taylor et al., 2008). In addition to cAMP 
binding to the regulatory subunits, threonine 197 of the activating loop in the catalytic subunit 
must be phosphorylated by phosphoinositide-dependent protein kinase 1 (PDK1) (Cheng et al., 
1998). PKA does not have intrinsic domains that control their localization, rather PKA requires 
the scaffolding protein AKAP to localize to specific sites. AKAP controls the localization of PKA 
by binding to the regulatory subunits. There are over 50 different AKAPs that localize PKA to 
the plasma membrane, mitochondria, or the cytoskeleton. Furthermore, AKAPs bring together 
PKA with other signaling molecules such as receptors, kinases, and channels (Wong and Scott, 
2004).  
The best characterized PKA substrate is the transcription factor cAMP response element 
(CRE) binding protein (CREB), which binds to CRE sequences in gene promoters and 
subsequently regulates transcription. The first step in CREB activation is the transport of PKA 
into the nucleus. This is mediated by A-kinase interacting protein 1 (AKIP1) (Sastri et al., 2005). 
CREB is activated upon phosphorylation of serine 133 by PKA. Phosphorylation of CREB 
augments its association with the co-activators CREB-binding protein (CBP) and p300. CBP and 
p300 catalyzes histone acetylation in the promoter, thus aiding transcription by recruiting DNA 
polymerase II complexes. CREB is regulated by co-activators called cAMP-regulated 
transcriptional co-activators (CRTCs). In the inactive state, CRTCs are bound to 14-3-3 proteins 
in a phosphorylation-dependent manner. When cAMP and calcium levels rise, calcineurin 
dephosphorylates the CRTCs, which triggers nuclear translocation of the CRTCs and 
subsequent activation of CREB. In addition, the elevated cAMP inhibits salt-inducible kinases 
that phosphorylate and thus inhibit CRTCs. This model where the calcium and cAMP pathways 
cooperate may explain results where CREB-phosphorylation on serine 133 has no effect on 
gene expression (Altarejos and Montminy, 2011). In thyroid cells, many but not all effects 
leading to proliferation by activation of the TSHR/cAMP/PKA-pathway are mediated by CREB 
(Rivas and Santisteban, 2003).   
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2.3.4 Exchange protein activated by cAMP 
All effects mediated by cAMP are not a result of activated PKA. The exchange protein activated 
by cAMP (EPAC) is a GEF for the small GTPase Rap1 (de Rooij et al., 1998). There are two 
isoforms of EPAC; EPAC1 is ubiquitously expressed while EPAC2 is mostly expressed in the 
brain. Both EPACs have a N-terminal regulatory domain and a C-terminal catalytic domain. The 
regulatory domain directly interacts with and inhibits the catalytic domain when cAMP is not 
present. Upon cAMP-binding to the regulatory domain, the conformation changes and 
inhibition is removed (Borland et al., 2009; Breckler et al., 2011). 
EPAC/Rap1 controls integrin-mediated adhesion to fibronectin in response to stimulation 
of Gsα-coupled receptors (Rangarajan et al., 2003). Moreover, EPAC/Rap1 increases adhesion 
to other cells through vascular endothelial cadherin (Fukuhara et al., 2005). One possible 
mechanism for increased adhesion is that EPAC/Rap1 promotes activation of Rac1-specific 
GEFs (Birukova et al., 2007). Moreover, EPAC/Rap1 mediates the anti-inflammatory effects of 
cAMP in vascular endothelial cells (Sands et al., 2006). 
Another downstream effector of EPAC/Rap is PLCε. EPAC1 induces calcium mobilization 
from intracellular stores by activating Rap2b, which subsequently activates PLCε (Schmidt et 
al., 2001). However, results showing PLCε-activation by Rap1 have also been reported (Song et 
al., 2002; Baljinnyam et al., 2010). The importance of EPAC-activated PLCε has been shown in 
several model systems. For example, PLCε was involved in regulating both the migration of 
melanoma cells (Baljinnyam et al., 2010) and the acrosome reaction of human sperm cells 
(Branham et al., 2009). 
Like for many other signaling molecules, not only the activity but also the localization of 
EPAC is important for the function (Breckler et al., 2011). The muscle-specific AKAP, mAKAP 
has been implicated in coordinating cAMP signaling by providing a platform for PKA, PDE4D3, 
and EPAC1 (Dodge-Kafka et al., 2005). Furthermore, AKAP9 was shown to be important for 
EPAC1-mediated integrin adhesion (Sehrawat et al., 2011). The translocation of EPAC1 to the 
plasma membrane requires the activation of ezrin-radixin-moesin proteins, which function as 
scaffold proteins that directly bind to EPAC1 upon receptor activation. In addition, the 
translocation of EPAC1 to the plasma membrane was crucial for EPAC1-mediated cell adhesion 
(Ponsioen et al., 2009; Gloerich et al., 2010). 
 
2.4 ERK1/2 signaling 
 
Cells respond to a multitude of different stimuli by activating the mitogen-activated protein 
kinase (MAPK) pathways (Meloche and Pouyssegur, 2007; Raman et al., 2007). There are three 
major pathways in the MAPK family, the ERK1/2, the p38 kinase, and the c-jun N-terminal 
kinase pathway. The regulation and significance of the ERK1/2 pathway will be discussed here. 
However, a comprehensive overview of the ERK1/2 pathway is beyond the scope of this thesis, 
only the general regulation mechanisms are discussed herein. The ERK1/2 pathway is activated 
by a three-module phosphorylation cascade starting with RAF, then MAP/ERK kinase (MEK) 
and ending with the phosphorylation of ERK1/2. Many of the signaling pathways leading to 
activation of ERK1/2 go through the small GTPases of the Ras family and G-proteins (Figure 5). 
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Figure 5. ERK signaling regulated by GPCRs and RTKs. Activation of PLC increases the 
availability of calcium, which activates Src through CaM and Pyk2. Src phoshphorylates 
tyrosine residues on RTKs, thereby activating them. Activation of RTKs generates 
phosphorylated tyrosine residues, which are binding sites for Shc. Shc binds Grb2 and RasGEFs 
that activate the ERK pathway through Ras. -subunits of Gi-proteins are able to activate Src 
through PI3K. Activation of PLC also generates DAG that activates PKC. PKC circumvents Ras by 
directly activating C-Raf. Activation of ACs generates cAMP, which activates ERK through EPAC 
and Rap1 [modified from (May and Hill, 2008)]. 
 
 
 
 
2.4.1 Ras 
Rap GTPases function as cellular switches, activated when bound to GTP and inactive when 
bound to GDP. The activation and inactivation of Ras is controlled by GEFs and GAPs, 
respectively. RasGEFs stimulate the exchange of GDP for GTP and RasGAPs stimulate the 
GTPase activity of Ras, thus inactivating it (Karnoub and Weinberg, 2008; Vigil et al., 2010).  
A series of post-translational modifications is crucial for the membrane association of Ras 
and thus its activation (Karnoub and Weinberg, 2008). In a series of steps, farnesylation takes 
place on a C-terminal CAAX-motif. First, cysteine 186 is farnesylated (Hancock et al., 1989), 
then the remaining AAX amino acids are removed, and finally the now C-terminal cysteine 
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undergoes methylation (Gutierrez et al., 1989). Moreover, Ras has a palmitoylation domain 
next to the CAAX-motif. Together, these two post-translational modifications support the 
translocation of Ras to the plasma membrane (Hancock et al., 1990). In the early 1990’s, 
several groups reported simultaneously how Ras is coupled to receptor tyrosine kinases and 
activated. The scaffold protein, growth factor-bound protein 2 (GRB2) binds to phosphorylated 
tyrosine residues on the receptor with its SH2-domain. Furthermore, receptor-bound GRB2 
functions as scaffold and binds RasGEFs with a SH3-domain (Egan et al., 1993; Gale et al., 
1993; Li et al., 1993; Rozakis-Adcock et al., 1993). 
Calcium is able to directly activate a class of RasGEFs called RasGRF1 and RasGRF2, which 
stimulate the activity of Ras. There are also calcium/DAG regulated GEFs, called CalDAG-GEFs, 
which have a C1 domain that binds DAG and a calcium-binding EF-hand. However, only 
CalDAF-GEF2 activates Ras. Moreover, calcium regulates the shutdown of Ras signaling by 
activating two RasGAPs, p120 RasGAP and calcium-promoted Ras inactivator (Cullen and 
Lockyer, 2002). 
 
2.4.2 Rap1 
The Rap1 GTPase is another member of the Ras family that activates the ERK1/2 pathway 
through B-RAF (Vossler et al., 1997). Like Ras, Rap1 switches between an active GTP-bound 
state and an inactive GDP-bound state, which is regulated by GEFs and GAPs (Hattori and 
Minato, 2003; Gloerich and Bos, 2011). 
Rap1 has the same C-terminal CAAX domain as Ras (Kawata et al., 1988), but the domain 
seems to be geranylgeranylated instead of farnesylated like Ras (Kawata et al., 1990). It has 
been shown that geranylgeranylation induces membrane association in the same manner as 
farnesylation. However, the membrane binding affinity is stronger when modified by the 20-
carbon geranylgeranyl group, than the 15-carbon farnesyl group (Hancock et al., 1991). The 
importance of geranylgeranylation and translocation of Rap1 to membranes has been shown 
(Satoh et al., 2001). Moreover, Rap1 is translocated to the plasma membrane from endosomes 
in response to mitogens (Bivona et al., 2004). 
Interestingly, in addition to the already discussed EPACs, two isoforms of CalDAG-GEFs 
activate Rap1. There are reports showing DAG-mediated translocation of CalDAG-GEF3 and 
the activity of CalDAG-GEF1 is modulated by calcium (Guo et al., 2001; Hattori and Minato, 
2003; Gloerich and Bos, 2011). However, the regulation of CalDAG-GEFs by calcium and DAG is 
still controversial. CalDAG-GEF1 is not directly regulated by DAG, and calcium has had only 
minor modulatory effects on CalDAG-GEFs in some studies (Gloerich and Bos, 2011). 
 
2.4.3 The RAF protein kinase family 
Directly downstream of Ras and Rap1 is the serine/threonine kinase rapidly accelerated 
fibrosarcoma (RAF). There are three isoforms of RAF called A-RAF, B-RAF, and C-RAF (also 
known as RAF-1). Only the regulation of B-RAF and C-RAF will be discussed here. RAF kinases 
have three conserved regions, which contain the Ras-binding domain, a regulatory 
serine/threonine rich domain that binds the 14-3-3 protein, and the protein kinase domain, 
respectively. In addition to the inhibitory binding site for the 14-3-3 protein in the conserved 
region 2, there is a stimulatory site for the 14-3-3 protein after the kinase domain in the C-
terminus (Wellbrock et al., 2004; Roskoski, 2010). 
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In the inactive state, the 14-3-3 protein is bound to two phosphorylated serine residues of 
RAF and is located in the cytosol. The binding of a GTP-bound Ras to C-RAF and B-RAF recruits 
them to the plasma membrane. However, it is not enough to fully activate these kinases. The 
RAF proteins undergo conformational changes and require phosphorylation and 
dephosphorylation to acquire full activity (Wellbrock et al., 2004; Roskoski, 2010). C-RAF has 
several serine residues that are phosphorylated by PKA, namely serines 43, 233, and 259. 
Phosphorylation of these sites inhibits C-RAF activity. The serine/threonine kinase AKT has also 
been shown to phosphorylate serine 259. There are several phosphorylation sites that 
augment C-RAF activity. Phosphorylation of serine 621 is important for 14-3-3 binding to the C-
terminus, which stabilize the active conformation. Phosphorylation of serine 338 and tyrosine 
341 are crucial for the activity of C-RAF. Src kinase is the kinase responsible for the 
phosphorylation of tyrosine 341. Furthermore, the phosphorylation of threonine 491 and 
serine 494 in the kinase domain is needed for activation (Chong et al., 2001). Like for serine 
338, the kinase responsible for threonine 491 and serine 494 phosphorylation is still unclear. 
However, one explanation is that they are autophosphorylated (Wellbrock et al., 2004). Serine 
471 in the kinase domain of C-RAF is critical for kinase activity and interaction with MEK (Zhu 
et al., 2005). Mutation of the corresponding B-RAF site, serine 578, resulted in an inactive 
kinase. The authors speculate that this phosphorylation site is mimicked by the B-RAF V600E 
mutation, which is often seen in cancers (Zhu et al., 2005). Serine 728 in B-RAF, which is 
equivalent to serine 621 in C-RAF, is believed to have the same function in B-RAF, i.e. 14-3-3-
binding to the C-terminus (Wellbrock et al., 2004). Phosphorylation of threonine 598 and 
serine 601 in the activation segment is essential for B-RAF function (Zhang and Guan, 2000). In 
contrast to C-RAF, serine 445 in B-RAF, which is equivalent to serine 338 in C-RAF, is 
constitutively phosphorylated in B-RAF. As a result, B-RAF has high basal activity (Mason et al., 
1999). Membrane recruitment is the crucial activation step for B-RAF. It is thought that the 
high basal activity and the need for only a single point mutation is the reason why B-RAF 
mutations often are reported in cancer (Wellbrock et al., 2004). 
RAF dimerization is important for kinase activity. Both homo- and heterodimers are 
formed. Serine 621 in C-RAF is important for dimerization and C-RAF/B-RAF heterodimers are 
more active than either homodimer or monomers.  In addition, threonine 753 in B-RAF is 
phosphorylated by ERK, which has been shown to decrease dimerization (Rushworth et al., 
2006).  
 Feedback inhibition from ERK is a common inhibitory signal for both C-RAF and B-RAF 
(Wellbrock et al., 2004; Roskoski, 2010). ERK phosphorylates C-RAF on five sites (Dougherty et 
al., 2005), while B-RAF has four inhibitory ERK-phosphorylation sites that inhibit Ras-binding 
and B-RAF heterodimerization with C-RAF (Ritt et al., 2010). 
 
2.4.4 The MEK protein kinases 
The only well-characterized and widely accepted substrates for RAF are MEK1/2. RAF activates 
MEK1 by phosphorylation of serine 218 and 222 within the activation segment (Zheng and 
Guan, 1994). The corresponding residues on MEK2 are serine 222 and 226. MEKs have a ~290 
amino acid protein kinase domain and smaller N- and C-terminal segments of ~30 and ~70 
residues, respectively. MEK1/2 are dual-specificity kinases as they phosphorylate both tyrosine 
and threonine residues. The N-terminus contains the ERK-binding domain, the nuclear export 
sequence, and an inhibitory segment (Roskoski, 2011). MEK1 is inhibited by phosphorylation 
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of four residues; serine 212 in the activation site (Gopalbhai et al., 2003), threonines 286 
(Rossomando et al., 1994) and 292 (Eblen et al., 2004) in the the kinase domain, and threonine 
386 in the C-terminus (Brunet et al., 1994). Phosphorylation of threonine residues 292 and 386 
by ERK is important for negative feedback control (Brunet et al., 1994). The threonine 292 in 
MEK1 is essential for negative feedback control by ERK on MEK1/2 heterodimers, as MEK2 
lacks an equivalent residue (Catalanotti et al., 2009).  
 
2.4.5 ERK1/2 
The last kinases in this tightly regulated pathway are the serine/threonine kinases ERK1/2. 
ERK1/2 are activated by MEK1/2-induced phosphorylation of threonine 202 and tyrosine 204 
in ERK1 and threonine 185 and tyrosine 187 in ERK2, both of which are within respective 
kinase activation domain (Payne et al., 1991; Meloche and Pouyssegur, 2007). The 
phosphorylations are ordered, in the case of ERK2, phosphorylation of tyrosine 187 precedes 
phosphorylation of threonine 185 (Haystead et al., 1992). The nuclear export signal located in 
MEK functions as an anchor for ERK1/2 until it is activated. Upon phosphorylation, ERK1/2 is 
free to translocate to the nucleus (Adachi et al., 1999). 
ERK1/2 phosphorylates serine and threonine residues residing in a Pro-Xaa-Ser/Thr-Pro 
motif. In addition, ERK1/2 substrates contain several different domains that augment ERK1/2 
binding and thus phosphorylation. Examples of substrates that are phosphorylated by ERK1/2 
are transcription factors such as Elk1 and c-Fos, protein kinases such as p90 ribosomal s6 
kinase, and numerous other cytoplasmic targets (Pearson et al., 2001).    
The MAPK phosphatases (MPKs) dephosphorylate ERK1/2 and thus inactivate them. MKPs 
are regulated by different mechanisms (Liu et al., 2007). MKP1 is induced upon activation of 
ERK1/2 by immediate early genes (Sun et al., 1993). Furthermore, the stability of MKP1 is 
increased upon phosphorylation by ERK1/2, thus facilitating dephosphorylation (Brondello et 
al., 1999). Moreover, MKP1 has been shown to translocate to the nucleus where it inhibits 
ERK1/2-induced phosphorylation of Elk1 (Wu et al., 2005). For MKP3, the binding to ERK1/2 is 
enough to increase phosphatase activity (Camps et al., 1998). The MKP, DUSP5, binds and 
anchors inactive ERK1/2 in the nucleus (Mandl et al., 2005). In contrast, MKP3 
dephosphorylates ERK1/2 and anchors it to the cytoplasm (Karlsson et al., 2004).  
 
2.4.6 Regulation of the ERK1/2 pathway by GPCRs 
There are well-documented effects of GPCR-mediated activation of the ERK-pathway through 
various mechanisms (Goldsmith and Dhanasekaran, 2007; May and Hill, 2008). The Gsα-
protein activates ERK1/2 by increasing cAMP which activates an EPAC/Rap1/B-Raf pathway 
(Vossler et al., 1997; Laroche-Joubert et al., 2002). Depending on cell type, another RapGEF 
than EPAC is responsible for Gsα-mediated activation of ERK1/2. In this pathway, PKA activates 
Src, which subsequently activates a RapGEF called C3G (Obara et al., 2004; Weissman et al., 
2004; Wang et al., 2006). Gsα is further able to negatively regulate ERK1/2 by activating PKA 
that inhibits C-Raf by phosphorylating serine 259 (Dhillon et al., 2002). 
The Giα-subunit may inhibit or activate ERK1/2 in a cell type-dependent manner. If the cell 
type is inhibited by cAMP, Gi-proteins are able to reverse this by directly inhibiting ACs 
(Hanoune and Defer, 2001; Cooper, 2003). Furthermore, the Giα-subunit binds and activates a 
Rap1GAP, thus inactivating Rap1 that antagonizes Ras-signaling (Cook et al., 1993; Okada et 
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al., 1998; Mochizuki et al., 1999). The Giβγ-subunit, on the other hand, is able to activate 
ERK1/2 via Src, which activates Ras by phosphorylating receptor tyrosine kinases. The 
phosphorylated tyrosine residue attracts the adaptor protein Shc, which subsequently binds to 
GRB2 and RasGEF. Two different pathways have been shown by which the Giβγ-subunit might 
activate Src. First, it has been shown that the Giβγ-subunit activates PI3K (Stephens et al., 
1994; Lopez-Ilasaca et al., 1997). Second, the Giβγ-subunit activates PLC, which subsequently 
activates calcium release and CaM-mediated activation of the protein tyrosine kinase Pyk2 
(Dikic et al., 1996; Della Rocca et al., 1997).  
The Gq/11α-subunit activates the ERK1/2 pathway using the same calcium-activated 
pathway as the Giβγ-subunit (Dikic et al., 1996; Della Rocca et al., 1997). Interestingly, the Gqα-
subunit has been shown to activate ERK1/2 through a Rap1/B-Raf mediated pathway. 
Moreover, the authors showed that calcium activated Rap1 via CalDAG-GEF1 (Guo et al., 
2001).  
All G-proteins that activate PLC are able to positively regulate the ERK1/2 pathway through 
conventional and novel PKCs (Goldsmith and Dhanasekaran, 2007; May and Hill, 2008). PKC 
activates C-RAF directly without the involvement of Ras (Ueda et al., 1996). A possible 
mechanism could be that PKC phosphorylates and inhibits the C-Raf kinase inhibitory protein, 
which leads to activation of C-Raf (Corbit et al., 2003). Lastly, transactivation of receptor 
tyrosine kinases by GPCRs is also employed by cells, which is an additional pathway to ERK1/2 
activation mediated by GPCRs (Wetzker and Bohmer, 2003). 
 
2.5 The synthesis of thyroid hormones 
 
The thyroid gland is a major endocrine organ, whose sole function is to produce the thyroid 
hormones 3,5,3’,5’-tetraiodothyronine (T4) and 3,5,3’-triiodothyronine (T3) (Dunn and Dunn, 
2001). Low circulating levels of thyroid hormones are sensed by the hypothalamus, which 
produces TRH. Subsequently, TRH stimulates the pituitary to produce TSH, which stimulates 
the thyroid to produce thyroid hormones (Chiamolera and Wondisford, 2009). The thyroid has 
two interconnected lobes, one on each side of the trachea. There are two hormone-producing 
cell types in the thyroid, the thyroid hormone-producing epithelial (also known as follicular) 
cells and calcitonin-producing parafollicular cells. Histologically, the thyroid consists of 
spherical structures called follicles surrounded by connective tissue and blood capillaries. The 
follicles are comprised of mostly epithelial cells that enclose the lumen of the follicle. The 
precursor of thyroid hormones, thyroglobulin (Tg), is stored in the lumen. The thyroid-specific 
transcription factors paired box (Pax)-8, thyroid transcription factor (TTF)-1, and TTF2 regulate 
the transcription of thyroid-specific genes beginning at embryonic day 8.5 in mice (Van Vliet, 
2003).   
Thyroid hormones are produced from the precursor Tg. After its synthesis, Tg forms stable 
dimers that are shuttled to the Golgi with the help of chaperones. In the Golgi, the 
glycosylated residues of Tg are processed where after it is transported in vesicles to the lumen 
of the follicle. Iodide is taken up into the epithelial cells at the basal side by the sodium iodide 
symporter (NIS). Iodide moves with the electrochemical gradient to the apical, lumen-facing, 
side of the epithelial cell. Iodination of Tg takes place at the apical membrane, where thyroid 
peroxidase (TPO) iodinates tyrosine residues on Tg and subsequently produces 
iodothyronines. Next, the newly iodinated Tg is taken up by micropinocytosis and goes 
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through the endosomes and lysosomes where Tg is degraded and T4 and T3 are released from 
the now obsolete Tg scaffold. The newly formed thyroid hormones are then released into the 
bloodstream (Dunn and Dunn, 2001). The thyroid hormones elicit negative feedback on the 
hypothalamus and the pituitary. This results in lowered secretion of TRH and TSH, respectively 
(Chiamolera and Wondisford, 2009). 
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3 AIMS 
 
The unifying factor for this study is calcium signaling, specifically conveyed by TRPC channels. 
The aims were to elucidate the functions of TRPC3 and TRPC2 channels and attempt to answer 
the following questions: 
 
1. What roles have overexpressed TRPC3 in cells, apart from conveying entry of 
extracellular calcium? 
 
2. Phosphatase inhibition revealed a calcium entry pathway in thyroid-derived FRTL-5 
cells. Is this calcium entry regulated by autocrine S1P-signaling? 
 
3. The aforementioned calcium entry in FRTL-5 cells was conducted by TRPC2. What 
function does TRPC2 have in thyroid cell signaling, and is there communication 
between the calcium- and cAMP-mediated signaling pathways? 
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4 EXPERIMENTAL PROCEDURES 
 
4.1 Cell culture and cell lines (I-III) 
 
Human embryonic kidney cells (HEK-293) were used for the study with overexpression of 
TRPC3 (I). HEK-293 cells were chosen as they are well suited for over-expression studies and 
show robust calcium signals in response to various agonists. MEM medium containing 10% 
fetal bovine serum, 2 mM L-glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin was used 
for growing HEK-293 cells. When the cells reached 80-90% confluency, they were detached 
with PBS + 0.02% EDTA + 0.1% trypsin and reseeded at a ratio of 1:8. 
Rat thyroid FRTL-5 cells were used for studying autocrine S1P signaling (II) and for 
elucidating the functions of TRPC2 in thyroid cells (III). FRTL-5 cells were grown in Coon’s 
modified Ham’s F12 medium supplemented with 5% calf serum, six hormones (insulin, 10 
µg/ml; transferrin, 5 µg/ml; hydrocortisone, 10 nM; tripeptide gly-L-his-L-lys, 10 ng/ml; TSH, 
0.3 mU/ml; somatostatin, 10 ng/ml), and 50 U/ml penicillin and 50 µg/ml streptomycin. FRTL-5 
cells were detached with PBS + 0.02% EDTA + 0.1% trypsin and reseeded at a ratio of 1:4. 
Primary rat thyroid cells were used for investigating what TRPC channels are expressed in 
vivo (III). Rat thyroid tissue was digested with 0.2% collagenase, and follicles were plated on 
poly-L-lysine coated plates in Coon’s modified Ham’s F12 medium supplemented with 1% FBS, 
0.3 mU/ml TSH and 1 µg/ml insulin to allow cells to attach. After three days, the medium was 
changed to serum-free Coon’s modified Ham’s F12 medium supplemented with 0.3 mU/ml 
TSH and 1 µg/ml insulin to allow thyroid cell survival and prevent the survival of other cell 
types (Eggo et al., 1996). After two weeks in serum-free conditions, the cells were used for 
experiments.  
All cells were grown in a water-saturated atmosphere of 5% CO2 and 95% air at 37°C. 
 
4.2 Plasmid constructs (I-III) 
 
The YFP plasmid (pEYFP-N1) was from Clontech (Mountain View, CA, USA). The TRPC3 
plasmids pCAGGSM2_GFP and pcDNA3h-TRP3topaz were kindly provided by Dr. Bernd Nilius 
(KU Leuven, Leuven, Belgium) and Dr. James Putney, Jr (NIH/NIEHS, Reasearch Triangle Park, 
NC, USA), respectively. The expression vector pCMV6-XL4-SK2 was purchased from Origene 
(Rockville, MD, USA). SK2 was cut out with Not1 and subcloned into a pcDNA3 vector. The SK2 
insert was confirmed by sequencing. The truncated form of TRPC2 (TRPC2-DN) was a kind gift 
from Dr. Genevieve Bart (University of Eastern Finland, Kuopio, Finland). MEK1-S218E/S222D 
and MEK1-K97M was originally obtained from Dr. Natalie Ahn (University of Colorado, 
Boulder, CO, USA). The PDE4D3 construct was originally obtained from Dr. Marco Conti 
(University of California, San Francisco, CA, USA). N-EPAC was kindly provided by Dr. Daniel 
Altschuler (University of Pittsburgh, PA, USA). The Rap1A
N17
 construct was originally obtained 
from Dr. Jean de Gunzburg (Institut Curie, Paris, France). The RTP1 plasmid was kindly 
provided by Dr. Debra Fadool (Florida State University, Tallahassee, FL, USA). The rat GFP-
TRPC2 construct was made as follows. The rat TRPC2 cDNA was a gift from Dr. Catherine Dulac 
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(Harvard University, Cambridge, MA, USA). The cDNA was cut out from the pBluescript cloning 
vector with BamHI and NcoI. After blunting the NcoI site, the fragment was subcloned into 
pEGFP-C3 (Clontech) cut with BglII and SmaI. By using the BamHI site, the initiator methionine 
was deleted from the TRPC2 gene and the fusion generated the EGFP-TRPC2 construct. 
 
4.3 Transfections (I-III) 
 
4.3.1 Calcium phosphate precipitation (I) 
HEK-293 cells are easily transfected cells and calcium phosphate precipitation is an affordable 
way of transfecting cells. Cells were seeded on poly-L-lysine coverslips in a 35-mm plate and 
allowed to attach over night. A DNA precipitate was made by mixing HEPES-buffered saline 
(280 mM NaCl, 10 mM KCl, 1.5 mM Na2HPO4, 50 mM HEPES, and 12 mM D-glucose, pH 7.05) 
with plasmid DNA dissolved in Tris-EDTA-CaCl2 (1mM Tris base, 0.1 mM EDTA, and 0.26 M 
CaCl2, pH 8.0). The resulting mixture was incubated for 20 min at room temperature to allow 
the precipitate to form. The precipitate was then resuspended and added to the cells. The 
medium was removed after 4 hours of incubation in the incubator. The cells were then treated 
with 15% glycerol in HEPES-buffered saline for 1 min to improve transfection efficacy. Normal 
growth medium was added after a wash with PBS, and the cells were thereafter returned to 
the incubator. Cells were used for experiments after 24h.  
  
4.3.2 Fugene HD (II) 
Fugene HD (Roche, Indianapolis, IN, USA) was used in some experiments to transfect FRTL-5 
cells. Cells were grown to 70% confluency prior to starting the experiment. Plasmid DNA and 
transfection reagent was diluted in OptiMem (Invitrogen, Carlsbad, CA, USA). The amount of 
DNA and reagent was scaled to the size of the plate according to the manufacturer’s 
instructions. Experiments were performed 24 h after transfection. 
 
4.3.3 Electroporation (III) 
Electroporation was the most reliable method to get a large amount of FRTL-5 cells 
transfected with various plasmid constructs. Cells from a 100-mm plate were detached and 
counted, 4 × 10
6
 cells were centrifuged down and resuspended in 400 µl OptiMEM (Invitrogen, 
Carlsbad, CA, USA) together with 20 µg plasmid DNA. The cells were then electroporated in 
BTX cuvettes (975 µF and 240 V) using a Bio-Rad Gene Pulser Xcell (Bio-Rad Laboratories, 
Hercules, CA, USA). The electroporated cells were used for experiments after 48-72 h. 
 
4.3.4 Generation of a stable TRPC2 knockdown cell line (III) 
FRTL-5 cells were plated on 12-well plates. The following day transfections were carried out 
with Fugene HD and shRNA plasmids (SABiosciences, Frederick, MD, USA) according to the 
manufacturers’ instructions. 48 h post-transfection, puromycin (1 µg/ml) was added to the 
growth medium to kill untransfected cells. Puromycin was included in the growth media from 
here on.  
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4.3.5 Transduction of FRTL-5 cells with SK1WT and SK1G82D (II)  
Human SK1 cDNA was cloned and FLAGtagged at the 3’ end according to Pitson et al. (Pitson et 
al., 2000a; Pitson et al., 2000b). The SK-FLAG fragment was PCR-amplified by using primers 
with 5’ MluI and 3’ SalI sites and cloned into the WPT-GFP lentiviral vector, which had been 
digested with MluI and SalI to remove the GFP gene. Lentiviral vectors expressing the SK-FLAG 
construct were produced by transient three-plasmid co-transfection into HEK 293T cells by 
using calcium phosphate precipitation. The three-plasmid mixture consisted of 14.5 µg WPT-
SKFLAG, 8.3 µg pCMVΔR8.91, and 2.1 µg MD.G (all plasmids were a kind gift from Dr. D. Trono, 
Lausanne, Switzerland). The virus-containing medium was harvested 48 h later by filtering 
through a 0.45 µm filter and centrifugation at 16,000 × g for 2.5 h at 4°C. The resulting virus 
pellets were resuspended in 200 µl serum-free DMEM. For transduction, FRTL-5 cells were 
plated on six-well plates (1×10
5
 per well), and 24 h later, virus together with 8 µg/ml 
Polybrene was added at multiplicity of infection 10 and incubated for 6 h after which time the 
medium was replaced with fresh medium.  
 
4.4 Calcium measurements (I-III) 
 
4.4.1 Cell suspension (II) 
The medium was aspirated, and the FRTL-5 cells were detached and washed three times in 
HBSS. After washing, the cells were incubated with 1 µM Fura-2 AM (Invitrogen, Carlsbad, CA, 
USA) (30 min, 37°C) in HEPES-buffered salt solution (HBSS) consisting of 118 mM NaCl, 4.6 mM 
KCl, 1 mM CaCl2, 10 mM glucose and 20 mM HEPES (pH 7.4). The cells were then washed twice 
with HBSS buffer, incubated for 15 min at room temperature, and then washed once more. 
Fluorescence was measured with a Hitachi F2000 fluorometer using excitation wavelengths of 
340 and 380 nm and detecting emission at 510 nm. The signal was calibrated by the addition 
of 1mM CaCl2 and Triton X-100 to obtain maximum fluorescence. To obtain minimum 
fluorescence, Tris base was first added to elevate the pH above 8.3, then all calcium was 
chelated with 5mM EGTA. [Ca
2+
]i was calculated as described (Grynkiewicz et al., 1985), using a 
Kd value of 224 nM for Fura-2. 
 
4.4.2 Adherent cells (I, III) 
Cells cultured on poly-L-lysine coated coverslips were washed twice with HBSS and incubated 
with 2 μM Fura-2 AM for 30 min at room temperature. The cells were then washed with HBSS. 
The coverslip was placed in a perfusion chamber that was mounted on a Zeiss Axiovert 35 
microscope. The 340 nm and 380 nm excitation filters were used and emission was measured 
at 510 nm. Light was obtained from an XBO 75W/2 xenon lamp. The shutter was controlled by 
a Lambda 10-2 control device (Sutter Instruments, Novato, CA, USA), and images were 
collected with a SensiCam CCD camera (PCO/CD Imaging, Kelheim, Germany). The images 
were processed using Axon Imaging Workbench 5.1 software (Axon Instruments, Foster City, 
CA, USA). The experiments were performed at room temperature. For experiments in calcium-
free HBSS, CaCl2 was omitted and 150 µM EGTA added. The F340/F380 ratio was used as a 
measure of intracellular calcium concentrations.  
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For experiments on permeabilized cells, cells were plated on poly-L-lysine coated 
coverslips. Cells were loaded with 3 μM mag-Fura-2 AM for 45 min at 37 °C and then washed 
with KCl rinse buffer (125 mM KCl, 25 mM NaCl, 10 mM HEPES and 0.2 mM MgCl2, pH 7.25). 
Cells were then permeabilized with intracellular buffer (KCl rinse buffer with 200 μM CaCl2 and 
500 μM EGTA, pH 7.25) containing 10 μg/ml digitonin. The permeabilization process was 
monitored continuously. When approximately 80 % of the cells were permeabilized, excess 
digitonin was rinsed away by perfusion with intracellular buffer. 
 
4.5 Qualitative and quantitative polymerase chain reaction (III) 
 
Cells were grown on 60-mm plates. The plates were washed once with ice-cold PBS and RNA 
was isolated using the Aurum Total RNA Mini Kit (Bio-Rad Laboratories, Hercules, CA, USA) 
according to the manufacturer’s instructions. RNA quality and integrity was tested by 
absorbance spectrometry and by agarose gel electrophoresis, respectively. RNA 
concentrations were determined using the RiboGreen RNA Quantitation Reagent (Molecular 
Probes, Eugene, OR, USA). Reverse transcriptase reactions were performed on 0.25 µg RNA 
using SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) and Oligo(dT)15 
primers (Promega, Madison, WI, USA) following the manufacturers’ instructions. 
The PCR was performed in 50 µl reactions (5 µl cDNA, 1 mM primers, 200 nM each of dATP, 
dCTP, dGTP and dCTP, 0.5 U DynaZyme EXT DNA polymerase) on a Mastercycler gradient 
thermal cycler (Eppendorf, Hamburg, Germany) with an activation step at 94°C for 5 min 
followed by 30 cycles with strand separation at 94°C for 30 s and annealing for 60 s 
(temperatures listed in Supplementary Table 1) followed by elongation at 72°C for 60 s.  
Negative controls, where reverse transcriptase was omitted from the cDNA reaction, were 
performed to rule out that the RNA samples were contaminated with genomic DNA. The PCR 
products were separated by gel electrophoresis and visualized with ethidium bromide under 
UV-light.  
Quantitative PCR assays were designed using the Universal ProbeLibrary Assay Design 
Center (Roche, Basel, Switzerland). qPCR rections of 10 µl were used, containing 100 nM UPL 
probe or 200 nM normal length probe, 300 nM forward and reverse primers, 1x ABsolute 
QPCR Rox Mix (Abgene, Rochester, NY, USA) and cDNA. The Absolute QPCR Rox Mix contains 
Thermo-start DNA polymerase, proprietary reaction buffer, dNTPs and ROX reference dye. The 
qPCR was performed with the Applied Biosystems 7900HT Fast Sequence Detection System 
with a 15 min activation step at 95°C and 40 cycles with a strand separation step in 95°C for 15 
s and an annealing and elongation step at 60°C for 1 min. The amplification results were 
analyzed using SDS and RQ Manager Programs (Applied Biosystems, Foster City, CA, USA). 
 
4.6 Immunocytochemistry (I) 
 
For confocal microscopy, the cells were washed with cold PBS, and then fixed using 2% 
paraformaldehyde in PBS for 10 min. Next, the cells were washed three times with PBS and 
treated with 1% Triton-X in PBS for 3 min, followed by three washes with PBS. After incubation 
with blocking solution (PBS containing 1% serum and 0.2% Tween) for 20 min, the cells were 
incubated overnight at 4
o
C with primary antibodies in blocking solution. After three washes 
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with PBS, secondary antibodies were added and the coverslips were incubated in a humidified 
chamber for 1 h. The coverslips were washed three times with PBS, and were then mounted 
on a slide with Mowiol. For each staining there was a negative control that was not incubated 
with primary antibody. The images were acquired using a Leica TCS SP confocal microscope 
(Leica, Heidelberg, Germany) equipped with an Argon-Krypton laser (Omnichrome, Melles 
Griot,
 
Carlsbad, CA, USA). 
 
4.7 Sphingosine kinase activity assay (II) 
 
The activity of SK1 and SK2 was assessed as described previously (Olivera et al., 2000). Cells 
were suspended in assay buffer containing 20 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.5 mM 
deoxypyridoxine, 15 mM NaF, 1mM 2-mercaptoethanol, 1 mM sodium orthovanadate, 
10µg/ml leupeptin, 10 µg/ml aprotonin, 8.64 mg/ml β-glycerophosphate, 4 mM 
phenylmethylsulfonyl fluoride, 20 % glycerol, and 20 µg/ml trypsin inhibitor. The cells were 
lysed by freeze-thawing followed by brief sonication. The lysate was transferred to centrifuge 
tubes and centrifuged (105,000×g at 4°C for 90 min). The supernatant was stored at -85°C. 
Total protein concentration was measured with the Bio-Rad protein assay. The activity of SK 
was measured with 200 µg total protein at 37°C for 30 min with [γ-
32
P]ATP and either 50 µM 
D-erythro-sphingosine-BSA (1 mM D-erythro-sphingosine in 4 mg/ml BSA) complex or 50 µM 
D-erythro-sphingosine-Triton X-100 (1 mM D-erythro-sphingosine in 5% Triton X-100). The 
reaction was stopped by putting the tubes on ice and adding HCl followed by addition of 
chloroform/methanol/HCl, (100:200:1, vol/vol). The tubes were vortexed, and after 10 min, 
chloroform and KCl were added together with 10 nmol of D-erythro-sphingosine-1-phosphate 
(carrier) for phase separation. After 10 min, the tubes were centrifuged (600×g for 10 min), 
and an aliquot of the organic phase was applied to high performance thin-layer 
chromatography plate and eluted in a horizontal chamber with 1-butanol/H2O 
/methanol/acetic acid, (80:20:20:10, vol/vol). The activity was assessed using autoradiography. 
 
4.8 Sphingosine-1-phosphate production assay (II) 
 
Prior to the experiment, cells were incubated overnight in medium with hormones and 0.2% 
fatty acid-free BSA. Cells were then stimulated with agonist or vehicle together with 
[
3
H]sphingosine (~200,000 cpm). Lipids were extracted by aspirating the culture medium and 
adding 500 µl ice-cold methanol to the cells, after which the cells were scraped from the Petri 
dishes and transferred to Eppendorf tubes. The tubes were sonicated for 5 min and then 
centrifuged (6000×g for 10 min) to remove cell debris. The supernatant was transferred to 
glass vials. S1P was added to each sample for identification, and the supernatant was 
evaporated. [
3
H]S1P was extracted from the medium as previously described (Johnson et al., 
2002a). After re-dissolving in methanol, the samples were spotted onto high-performance 
thin-layer chromatography plates and separated with butan-1-ol/acetic acid/water (3:1:1, 
vol/vol). S1P was stained with ninhydrin, spots were scraped, and the formed [
3
H]S1P was 
counted using liquid scintillation. 
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4.9 Western blotting (III) 
 
Cells were washed three times with ice-cold PBS, and scraped in lysis buffer (10 mM Tris/HCl 
(pH 7.7), 150 mM NaCl, 7 mM EDTA, 0.5 % NP-40, 0.2 mM PMSF, and 0.5 µg/ml leupeptin). 
The lysates were incubated on ice for 15 minutes and then centrifugated at 10,000 x g for 15 
min. Proteins were separated by 6-15 % SDS-PAGE, depending on the size of the protein of 
interest, and then transferred onto a nitrocellulose membrane. Membranes were incubated 
with the primary antibody of interest and an HRP-linked secondary antibody. Protein bands 
were detected using enhanced chemiluminescence. The Image J program (Abramoff et al., 
2004) was used to quantify band intensities. 
 
4.10 Immunoprecipitation of secreted thyroglobulin (III) 
 
Cells were plated on 100-mm plates and grown in 6H medium. After 48 h, aliquotes of the 
medium were collected and incubated with goat anti-Tg antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA). The samples were incubated under rotation over-night at 4°C. The 
following day, protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) were added and 
the samples where incubated for an additional 2 h. The beads where pelleted by 
centrifugation (1000 x g, 2 min) and washed three times with immunoprecipitation wash 
buffer (50 mM Tris pH 7.5, 250 mM NaCl, 0.1% NP-40, 0.05% sodium deoxycholate). After the 
last wash the beads where resuspended in Laemmli buffer and boiled for 5 min. The beads 
were pelleted by centrifugation and the supernatant was separated on a 6 % SDS-PAGE gel. 
Proteins were then transferred onto a nitrocellulose membrane and incubated with goat anti-
Tg primary antibody and mouse anti-goat HRP-linked secondary antibody (Santa Cruz 
Biotechnology). The amount of secreted Tg was normalized to intracellular Tg from respective 
cell lysate. 
 
4.11 cAMP assay (III) 
 
Cells were plated on 24-well plates and grown in growth medium for 24 hours. The cells were 
stimulated for 30 min with agonists in a humidified 5 % CO2 atmosphere at 37
o
C. A 
phosphodiesterase inhibitor (3-isobutyl-1-methylxanthine (IBMX), 100 µM) was included in the 
medium during the stimulations. The incubation was terminated by three washes with cold 
PBS. Cells were lysed with 300 μl/well 0.1 M HCl containing 0.1 % Triton X-100 for 10 min. 
Cyclic AMP concentrations in the samples were determined with Direct Cyclic AMP Enzyme 
Immunoassay Kit (AssayDesigns Inc., Ann Arbor, MI, USA) according to the manufacturer’s 
instructions. Levels of cAMP in the samples were normalized to mg protein in the respective 
sample.  
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4.12 Electrophysiology (III) 
 
Cells were plated at low density on 13-mm coverslips. Recordings were made at room 
temperature (23 25 C). Coverslips were placed in a chamber of 200 µl and continuously 
perfused at flow rate of 700 µl min
1
 with an extracellular solution comprised of 150 mM NaCl, 
5.4 mM CsCl, 3.0 mM CaCl2, and 5 mM HEPES (pH 7.40 with NaOH). Patch pipettes (3 8 M ) 
were filled with a solution containing 135 mM Cs-Methanesulfonate, 10 mM CsCl, 4.25 mM 
Na2ATP, 0.5 mM LiGTP, 125 µM EGTA, 10 mM HEPES (pH 7.20 with CsOH). The liquid junction 
potential of 15 mV was estimated with JPCalc software (Barry, 1994) and was subtracted off-
line.  
Whole-cell membrane currents (Hamill et al., 1981) were recorded with an EPC 9 amplifier 
and Pulse software (HEKA Elektronik, Lambrecht, Germany). Cells were stimulated with a 
series of rectangular voltage pulses (ranging from −135 mV to +105 mV, increment 10 mV and 
duration 100 ms) that was preceded and followed by 100 ms and 50 ms steps to –95 mV. The 
protocol was applied at 2 s intervals, during which cells were held at 15 mV. Whole-cell 
capacitance and series resistance were 80% compensated for and currents were sampled at 20 
kHz and filtered at 10 kHz.   
Analysis and graphics were done using PulseFit (HEKA Elektronik, Lambrecht, Germany) 
and Origin (OriginLab, Northampton, MA, USA) software. Mean current level in the end of 
voltage pulse series was measured (time window 10 ms). 
 
4.13 Statistics (I-III) 
 
Results are expressed as means ± SEM from at least three independent experiments. Student’s 
t test was used when two means were compared. One-way ANOVA and Bonferroni’s post hoc 
test was used when three or more means were compared. Two-way ANOVA was used for 
comparing concentration-responses. A P-value less than 0.05 was considered statistically 
significant. 
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5 RESULTS AND DISCUSSION 
 
5.1 Activation mechanisms of TRPC2 and TRPC3 (I, II, III, unpublished) 
 
The activation mechanisms of TRPC2 and TRPC3 have been elucidated in many previous 
studies (Venkatachalam and Montell, 2007; Birnbaumer, 2009). Both channel types have basal 
activity that is increased upon stimulation of PLC. Overexpressed TRPC3 showed a high level of 
basal activity (I, Figure 1), while the basal activity of endogenous TRPC2 was measurable only 
in patch-clamp experiments (III, Figure 1). Basal activity of TRPC3 has been shown previously 
(Zitt et al., 1997; Albert et al., 2006; DeHaven et al., 2009), whereas the basal activity of TRPC2 
has been reported to be smaller (Hofmann et al., 2000).  
The involvement of TRPCs in SOCE is highly debated with numerous reports showing 
conflicting results (Abramowitz and Birnbaumer, 2009; Salido et al., 2009). The results 
presented here show no involvement of overexpressed TRPC3 in SOCE (I, Figure 3). 
Furthermore, SOCE was not affected in TRPC2-knockdown (shTRPC2) cells (Sukumaran et al. 
manuscript submitted). Taken together, neither TRPC2 nor TRPC3 seem to affect SOCE in a 
significant manner.  
The most widely recognized TRPC activation mechanism is direct activation by DAG. 
Hofmann and colleagues were the first to show that TRPC3 is directly activated by the 
membrane-permeable DAG-analog 1-oleoyl-2-acetyl-sn-glycerol (OAG) (Hofmann et al., 
1999b). In agreement with this, overexpressed TRPC3 was strongly activated by OAG (I, Figure 
2). Like TRPC3, TRPC2 is activated by OAG (Lucas et al., 2003). In our hands, there were no 
TRPC2-mediated calcium transients in response to another DAG-analog, 1,2-dioctanoyl-sn-
glycerol (DOG) (results not shown). However, we never tested the effects of a DAG-analog on 
membrane currents in FRTL-5 cells. DOG does not seem to activate TRPC3 as potently as OAG 
(Hofmann et al., 1999b), which could explain why there were no effects of DOG on FRTL-5 
cells. In addition, overexpression of TRPC channels is necessary to acquire measurable effects 
of DAG-analogs (Hofmann et al., 1999b). In FRTL-5 cells there is a calcium influx unmasked by 
the serine/threonine phosphatase inhibitor calyculin A (caly A) (Gratschev et al., 2004). This 
calcium influx is mediated by a DAG-activated channel (II, Figure 4). The channel mediating this 
influx is TRPC2, as the caly A-mediated calcium influx was inhibited in shTRPC2 cells (Figure 6). 
Taken together, endogenously produced DAG might have a direct effect on TRPC2 under these 
special circumstances.  
FRTL-5 cells express several types of purinergic receptors that potently stimulate calcium 
release when stimulated with ATP (Ekokoski et al., 2001). In shTRPC2 cells, the ATP-induced 
calcium influx was severely hampered (III, Figure 1). As purinergic receptors activate PLC, both 
IP3 and DAG are produced. Although there is no direct evidence, it is feasible that DAG 
activates TRPC2 downstream of purinergic receptor activation, thus explaining why less 
calcium is entering the shTRPC2 cells when stimulated with ATP. 
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Figure 6. Caly A-evoked calcium entry is attenuated in shTRPC2 cells. Traces are the mean ± 
SEM of 4 separate measurements, P<0.05 for difference between cell populations. 
 
 
 
 
 
5.2 Localization of TRPC2 and TRPC3 
 
5.2.1 The effect of TRPC3 on intracellular calcium stores (I) 
It was clearly visible that overexpression of TRPC3 affected release of sequestered calcium 
from intracellular calcium stores, both when stimulated with a GPCR-agonist (S1P) or the 
SERCA-inhibitor thapsigargin (I, Figure 3, 6). By permeabilizing the cells, the content of the 
intracellular stores was measured. The basal level of calcium was significantly higher in control 
cells, as compared to TRPC3-overexpressing cells (I, Figure 4, 6). Moreover, when stimulated 
with ionomycin or IP3, the sequestered calcium was released and the new basal levels were 
indistinguishable. This indicates that the ER calcium concentration is lower in TRPC3-
overexpressing cells and that the result seen was not an effect of differences in the 
permeabilization process. Further, the localization of TRPC3 was investigated. TRPC3 was 
expressed in plasma membranes and in intracellular compartments, part of which localized to 
the ER, which was visualized with calnexin-staining (I, Figure 5). The plasma membrane 
localization of TRPC3 is not clearly visible in the images. In Figure 7, the localization of TRPC3 in 
both the plasma membrane and in an intracellular compartment is more readily apparent. An 
explanation for the reduced calcium content in TRPC3-overexpressing cells was not revealed. 
We speculated that TRPC3 might be functionally active in the intracellular compartment. In an 
attempt to test whether intracellular TRPC3 was functional, permeabilized cells were 
stimulated with OAG (results not shown). However, OAG elicited no response in permeabilized 
cells, which speaks against this hypothesis. The experiments on permeabilized cells are 
technically demanding and many intracellular proteins are presumably lost or damaged in the 
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permeabilization process. This could affect TRPC3 activation by OAG in the same manner as 
was seen with the lack of an effect of thapsigargin on permeabilized cells (I, Figure 4). Another 
plausible explanation is that OAG cannot reach the ER as it is trapped by the plasma 
membrane. 
 
 
 
 
 
 
Figure 7. Localization of overexpressed TRPC3. (A) TRPC3 was transiently overexpressed in 
HEK-293 cells and visualized with anti-TRPC3 and Alexa Fluor 568-antibodies. (B) Calnexin was 
used as a marker for the ER. Endogenous calnexin was visualized with anti-calnexin and Alexa 
Fluor 488-antibodies. (C) Overlay image from both channels. Arrows show ER and plasma 
membrane localization of TRPC3. Scale bar represents 10 µM.    
 
 
 
 
Several studies showing TRP superfamily members located in intracellular compartments 
have been reported. TRPV1 have been shown to localize both to the ER and the plasma 
membrane (Castro et al., 2009). Interestingly, the activation of TRPV1 and subsequent release 
of ER calcium did not result in activation of SOCE or translocation of STIM1 to the plasma 
membrane (Turner et al., 2003; Wisnoskey et al., 2003; Castro et al., 2009). That TRPV1 was 
located in a subcompartment of the ER that does not affect SOCE was speculated as the 
reason for this. Moreover, the subcompartment important for SOCE was located closer to the 
plasma membrane (Castro et al., 2009). TRPC1 is located in intracellular membranes when 
transiently expressed in HEK-293 cells. However, TRPC1 was located in the plasma membrane 
when it was co-transfected with TRPC4 or TRPC5, which indicates that heteromultimerization 
is important for the plasma membrane localization of TRPCs (Hofmann et al., 2002; Salgado et 
al., 2008). When TRPC1 was expressed alone, it formed functional calcium release channels in 
the ER (Salgado et al., 2008). It seems that TRP channels are able to function as putative ER 
calcium release channels, which supports our finding with TRPC3. However as we have no 
direct evidence, our conclusion remains hypothetical. Another possible explanation for our 
finding is that overexpression of TRPC3 affects SERCA activity or expression. 
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An error in the experimental setup might explain the lack of activation downstream of 
GPCR-activation. In our study, TRPC3-overexpressing cells were compared to non-transfected 
cells on the same coverslip. The control cells were chosen based on visible fluorescence from 
green fluorescent protein. The control cells might overexpress TRPC3, albeit at low levels, 
which enhances calcium signals. This could explain why no differences were seen between 
control and TRPC3-overexpressing cells. Moreover, low levels of TRPC3-overexpression have 
been shown to be important for activation by the PLC pathway (Putney, 2004). 
 
5.2.2 Requirement of RTP1 for the function of TRPC2 (III) 
The localization of TRPC2 was not studied in FRTL-5 cells. However, the ATP-induced calcium 
influx was severely decreased in shTRPC2 cells (III, Figure 1), which implies that TRPC2 is 
located on the plasma membrane. A class of transmembrane proteins, called receptor 
transporting proteins (RTPs), that are expressed in olfactory neurons are important for plasma 
membrane insertion of odorant receptors (Saito et al., 2004). Recently, a report showed that 
RTP1 forms a complex with the scaffold protein Homer and TRPC2, and this increased plasma 
membrane localization of TRPC2 (Mast et al., 2010). This may explain a previous study that 
showed retention of TRPC2 in intracellular membranes when heterologously expressed in HEK-
293 cells (Hofmann et al., 2000). When rescuing the effects of TRPC2 knockdown on calcium 
signaling, there was no requirement of additional proteins (III, Figure 7). In contrast, RTP1 was 
needed to reverse the effects seen on ERK1/2, TSHR, and Tg. Currently, I have no explanation 
for this. However, the calcium signal is an acute output, while protein phosphorylation and 
especially protein expression and post-translational modifications require correct signaling 
over a longer time-span. It is possible that RTP1 is important for sustained TRPC2 activity or 
transport back to the cell surface after internalization. At present there is no evidence for this, 
making this scenario highly hypothetical. In addition, the calcium signal in shTRPC2 cells 
expressing GFP-TRPC2 was only increased to the same level as in control cells. This indicates 
that additional proteins are probably needed to further enhance the calcium signal, e.g. the 
scaffold protein Homer.  
    
5.3 Activation of calcium entry via autocrine S1P-signaling (II) 
 
The ability of S1P to signal in an autocrine manner is believed to regulate such cellular 
processes as angiogenesis, survival, growth, and migration (Pyne and Pyne, 2010). The 
migration of cancer cells has been shown to be mediated by autocrine S1P signaling in several 
systems. In thyroid cancer cells, S1P is transported out in part by ABCC1 and activates 
migration through S1P-receptors (Bergelin et al., 2009). 
 
5.3.1 Sphingosine inhibits caly A-evoked calcium entry (II)  
The influence of autocrine S1P signaling on calcium signaling has not previously been reported. 
We showed that the sphingolipid rheostat and autocrine signaling of S1P affects calcium 
signaling in FRTL-5 cells (II). The serine/threonine phosphatase inhibitor caly A revealed a 
calcium entry pathway in FRTL-5 cells (Gratschev et al., 2004). Sphingosine has been shown to 
inhibit both VOCs (McDonough et al., 1994; Titievsky et al., 1998) and the ICRAC current (Mathes 
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et al., 1998), which is the electrophysiological term for SOCE. More recently, sphingosine was 
shown to inhibit STIM1 and Orai1 interactions, thus hampering SOCE (Calloway et al., 2009). In 
our study, sphingosine inhibited the caly A-induced calcium influx in a concentration-
dependent manner (II, Figure 1). Calcium entry was inhibited both with preincubation and with 
acute addition of sphingosine, the latter indicating that sphingosine has a direct effect on a 
channel. Other lipids had negligible effects on calcium entry, which shows that the effect is 
specific for sphingosine. 
 
5.3.2 Dual effects of SK1 on caly A-evoked calcium entry (II) 
Once the effects of sphingosine had been established, we investigated the possible 
involvement of SK. Overexpression of SK has previously been shown to remove inhibitory 
sphingosine from VOCs (Blom et al., 2006). In FRTL-5 cells, inhibition of SK had a similar effect 
on the calcium entry (II, Figure 2). Interestingly, addition of exogenous S1P rescued the 
calcium influx inhibited by an SK-inhibitor. This suggested that S1P is working through an 
autocrine mechanism. The effect of S1P on calcium signaling is not due to SOCE, as SOCE is 
inhibited by caly A. Moreover, intracellular stores are not affected by caly A, as only entry of 
calcium is of importance (Gratschev et al., 2004). Interestingly, activation of PLC through S1P2-
receptors was crucial for the calcium entry (II, Figure 3, 4). As IP3 is not important for caly A-
evoked calcium influx, it suggests that DAG is activating the entry. Inhibition of the ABCC1 
pump attenuated the calcium entry, which implies that this transporter shuttles S1P to the 
extracellular space where it activates the S1P2-receptor. ABCC1 has also been shown to 
transport S1P in other cell types (Mitra et al., 2006; Bergelin et al., 2009). In line with the 
hypothesis, exogenous S1P rescued the calcium entry when ABCC1 was inhibited. 
Overexpression of SK1, but not SK2, enhanced the calcium entry. Taken together, this shows 
that both removal of inhibitory sphingosine and the production of S1P is of importance for 
regulating caly A-evoked calcium entry.  At the time when the study was published, we had no 
knowledge which channel was involved. As already discussed, knockdown of TRPC2 reduced 
caly A-evoked calcium entry in FRTL-5 cells; this strongly suggests the involvement of TRPC2. 
 
5.3.3 Which phosphatase is involved? (II) 
Caly A-treatment increased the S1P concentration in FRTL-5 cells, but the mechanism is still 
unknown (II, Supplementary Table 1). There is evidence for involvement of protein 
phosphatases in sphingolipid metabolism. One of the phosphatases inhibited by caly A is 
protein phosphatase 2A (PP2A). This phosphatase has been shown to inhibit SK1 activity by 
dephosphorylating SK1 at serine 225 (Barr et al., 2008). However, the increase in S1P was not 
due to enhanced activity of SK1 or SK2 in FRTL-5 cells. This implies that S1P phosphatase, S1P 
lyase, or pathways leading to their activation are regulated by phosphorylation of 
serine/threonine residues. In a yeast model, the inactivation of PP2A circumvented the 
requirement for sphingolipid synthesis (Friant et al., 2000). This suggests that PP2A could 
affect sphingolipid metabolism. Furthermore, the pro-apoptotic sphingolipid ceramide 
activates PP2A (Dobrowsky et al., 1993). This is of importance in ceramide-induced apoptosis, 
as dephosphorylation and inactivation of anti-apoptotic Bcl2 is mediated by PP2A (Ruvolo et 
al., 1999). Moreover, ceramide-evoked activation of PP2A dephosphorylates and activates pro-
apoptotic Bax (Xin and Deng, 2006). In addition to ceramide, sphingosine may also activate 
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PP2A, as the immunosuppressive sphingosine analog, FTY720, activates PP2A (Matsuoka et al., 
2003). In contrast, S1P inhibits PP2A through activation of S1P2 (Salas et al., 2011). Although 
there is no evidence for regulation of S1P phosphatase by PP2A or any other phosphatase, 
sphingolipid and PP2A signaling is tightly intertwined, making this scenario at least 
hypothetically feasible.   
 
 
5.4 The importance of TRPC2 in thyroid cells (III, unpublished) 
 
The study describing autocrine S1P signaling turned our focus on TRPC channels in FRTL-5 
cells. A PCR screen revealed that only TRPC2 was expressed in these cells (III, Figure 1), which 
was surprising as several members of the TRPC family are regularly found in different cell lines. 
Transcripts for TRPC2 were detected both in primary thyroid cells and in freshly isolated rat 
thyroids. In contrast, TRPC2 was not expressed in mouse thyroid. There are no reports that 
TRPC2 knockout mice would have defective metabolism or thyroid hormone levels (Leypold et 
al., 2002; Stowers et al., 2002). 
 
5.4.1 Characterization of TRPC2 (III) 
To study the effects of TRPC2 in thyroid cells, cell lines stably expressing control RNA or small 
hairpin RNA directed against TRPC2 were produced. The resulting shC and shTRPC2 cell lines 
were then compared in an attempt to find new functions for TRPC2. The knockdown of TRPC2 
was verified with quantitative PCR only as no specific commercial TRPC2 antibody is available. 
That TRPC2 is functional in FRTL-5 cells was investigated by stimulation of purinergic 
receptors (III, Figure 1). A concentration-dependent increase in intracellular calcium was seen 
when stimulating the cells with ATP. In the presence of calcium, the increase in intracellular 
calcium was reduced in shTRPC2 cells at concentrations tested. In the absence of calcium, no 
differences were seen in calcium peak amplitudes. However, there seemed to be a small, but 
significant, decrease in the calcium released from the ER, apparently due to reduced SERCA 
activity (Sukumaran et al., submitted). Patch-clamp recordings supported the calcium imaging 
results. Dedifferentiation was not an issue in the shTRPC2 cells, as the expression of important 
thyroid-specific transcription factors, TTF1 and Pax8, was not affected (III, Supplementary 
Figure 2). 
     
5.4.2 Regulation of cAMP production by TRPC2 (III) 
The TSHR is the main regulator of thyroid cells and it activates mainly ACs and cAMP 
production through the GSα-subunit. This prompted us to investigate whether cAMP 
production is regulated by TRPC2. Stimulation of the cells with TSH or forskolin increased the 
cAMP concentration more potently in shTRPC2 cells as compared to shC cells (III, Figure 2). As 
PDEs activity was inhibited in the experimental setup, it suggests that AC activity and/or TSHR 
signaling might be affected. Both scenarios were true. The TSHR was upregulated on both 
mRNA and protein levels. Moreover, when the AC transcripts were screened it revealed the 
presence of AC5 and AC6, which both are inhibited by calcium. To investigate whether the 
decreased calcium signals seen in shTRPC2 cells are influencing cAMP production by AC5 and 
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AC6, the cAMP production assay was performed in the presence of the intracellular calcium 
chelator BAPTA-AM. In line with our hypothesis, calcium chelation increased cAMP in shC cells 
to the same level as seen in shTRPC2 cells. An extracellular calcium chelator, EGTA, was also 
tested. However, this chelator did not affect forskolin-induced cAMP production, only basal 
cAMP production (results not shown). Other studies have reported that BAPTA is a more 
effective chelator than EGTA when studying the effects of calcium on ACs (Willoughby and 
Cooper, 2007). Gq-mediated calcium signals have been shown to inhibit AC5 and AC6 (von 
Hayn et al., 2010). Defective SOCE signaling has been linked to activation of AC6 (Spirli et al., 
2012). Furthermore, it has been shown that SOCE mediated by STIM1 and Orai1 selectively 
activates AC8, while TRPC-mediated calcium influx is incapable of AC8 activation (Martin et al., 
2009). 
 
5.4.3 Connecting cAMP, ERK1/2 and TSHR expression (III, unpublished) 
As cAMP is able to activate the ERK1/2 pathway in thyroid cells (Iacovelli et al., 2001), we next 
studied whether increased cAMP production leads to phosphorylation of ERK1/2. The basal 
phosphorylation status of ERK1/2 in shTRPC2 cells was strongly induced when grown in the 
presence of serum and hormones including TSH (III, Figure 3). Acute stimulation of serum and 
hormone-starved cells with TSH more potently activated ERK1/2 in the shTRPC2 cells as 
compared to shC cells. Interestingly, in serum and hormone-starved cells both ATP and serum 
induced a stronger phosphorylation of ERK1/2 in shTRPC2 cells as compared to shC cells 
(Figure 8). This indicates that reduction of TRPC2 induces a global change that favors 
phosphorylation of ERK1/2 in FRTL-5 cells. 
 
 
 
 
 
Figure 8. The phosphorylation of ERK1/2 is enhanced in shTRPC2 cells. In serum and hormone-
starved cells, acute stimulation with serum (A) or ATP (B) more strongly phosphorylates 
ERK1/2 in shTRPC2 cells. Western blots are representative of three independent 
measurements.  
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Next we wanted to establish whether there is a link between reduced calcium entry and 
increased phosphorylation of ERK1/2 and the expression of the TSHR. In line with our 
hypothesis, chelation of extracellular calcium by EGTA or transient expression of a truncated 
non-conducting mutant of TRPC2 in native FRTL-5 cells resulted in increased phosphorylation 
of ERK1/2 and increased expression of the TSHR (III, Figure 4). Inhibition of MEK activity with a 
specific inhibitor (U0126) or expression of a constitutively active mutant of MEK1 in native 
FRTL-5 cells decreased and increased the expression of the THSR, respectively. These results 
strongly suggest that the MEK/ERK1/2 pathway is involved in regulating the expression of the 
TSHR. Finally, we inhibited the cAMP pathway by overexpressing PDE4D3 to reduce cAMP in 
the cells. This decreased the acute TSH-induced phosphorylation of ERK1/2 and the expression 
of the TSHR (III, Figure 5). Furthermore, by expressing a dominant negative mutant of Rap1, 
ERK1/2 phosphorylation and TSHR expression were reduced to control levels. Together, these 
results show that increased cAMP production in shTRPC2 cells activates ERK1/2 via Rap1 and 
this leads to increased expression of TSHR.  
 
5.4.4 Cross-communication between TRPC2 and cAMP (unpublished) 
 
In a previous study investigating caly A-mediated entry, PKA activity was crucial for the influx 
of calcium (Gratschev et al., 2004). If cells were grown in the absence of TSH, calcium entry 
was severely reduced, whereas it was rescued if TSH was added together with calcium. These 
two experiments suggest that PKA is phosphorylating an effector in this pathway, perhaps 
even the channel protein itself. As mentioned above, there is evidence for TRPC2 mediating 
the caly A-evoked entry of calcium. Moreover, there are putative PKA phosphorylation sites in 
TRPC2, mutation of which could answer many questions regarding the involvement of TRPC2. 
A model where TSH is able to activate TRPC2 through PKA-mediated phosphorylation and 
TRPC2 subsequently inhibits ACs and cAMP-production fits nicely with a classical negative-
feedback control mechanism. 
An additional level of cross-communication might be mediated by EPAC. When inhibiting 
EPAC by transiently transfecting a dominant negative form of EPAC (N-EPAC) into shC and 
shTRPC2 cells, a second level of cross-communication may have been revealed. Inhibition of 
EPAC in shTRPC2 cells decreased the TSHR expression to control level (Figure 9). This is in line 
with a model where increased cAMP production in shTRPC2 cells activates a Rap1/ERK1/2 
pathway, which increases the expression of the TSHR. In sharp contrast, when expressing N-
EPAC in control cells the TSHR expression increased to the same level as seen in shTRPC2 cells. 
To provide a possible explanation for this, ATP-induced calcium transients were measured in 
the presence of N-EPAC. Interestingly, N-EPAC increased the calcium transient in control cells, 
whereas it was without effect in shTRPC2 cells. These results suggest that EPAC may inhibit 
TRPC2 activity through a still unknown mechanism. In addition, TRPC2 increases the 
expression of the TSHR through an alternative pathway when EPAC is inhibited. 
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Figure 9. Inhibition of EPAC by expression of N-EPAC in shC and shTRPC2 cells. (A) TSHR 
expression is increased in shC and decreased in shTRPC2 cells by expressing a dominant 
negative mutant of EPAC (N-EPAC) as compared to control transfected cells (YFP). (B) 
Quantification of band densities in (A), bars indicates mean ± SEM, n=5, * P<0.05, ** P<0.01. 
(C) ATP-induced calcium transients in shC and shTRPC2 cells expressing YFP and N-EPAC. (D) 
Quantification of result in (C). Bars indicates mean ± SEM of n≥60 cells, * P<0.05, ** P<0.01.          
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5.4.5 TRPC2 and the secretion of thyroglobulin (III) 
 
The precursor for thyroid hormones, Tg, was studied as FRTL-5 cells do not secrete detectable 
levels of thyroid hormones. Interestingly, in shTRPC2 cells an additional lower molecular 
weight band appeared on the western blot (III, Figure 6). We speculated that this was an 
immature form of Tg as the protein goes through post-translational modification before it is 
secreted. Total Tg mRNA (III, Supplementary figure 2) or protein (III, Figure 6) was not altered 
in the shTRPC2 cells. This shows that only part of the Tg produced in shTRPC2 cells is fully 
processed. Glycosylation of Tg takes place in the ER before it is transported to the Golgi for 
further processing. With Endo H treatment of cell lysates from shC and shTRPC2 cells, we 
concluded that the immature form of Tg never reaches the Golgi. We base this on the finding 
that the mature form of Tg did not exhibit a mobility shift on the western blot and thus its 
sugar residues have been processed by Golgi α-mannosidase II, whereas the immature form of 
Tg has not. If part of the Tg is not transported to the Golgi for processing, this implies that less 
Tg is secreted from shTRPC2 cells. Indeed, by immunoprecipitating secreted Tg from the 
growth media of the cells, we showed that less Tg is secreted from shTRPC2 cells. The scenario 
described above probably partly describes the lesser secretion of Tg. However, as calcium is 
also involved in vesicular transport, we do not rule out that the reduced calcium transients 
seen in shTRPC2 cells could influence other mechanisms involved in the secretion of proteins, 
e.g. vesicular transport (Hay, 2007). 
 
5.4.6 The effects of TRPC2 knockdown are reversible (III)  
 
To conclude that the effects seen by knockdown of TRPC2 are due to specific effects, a series 
of rescue experiments where exogenous TRPC2 was added back to the cells were performed 
(III, Figure 7). The ATP-induced calcium transients were rescued in shTRPC2 cells by transient 
transfection with GFP-TRPC2. However, both the phosphorylation of ERK1/2 and the 
expression of the TSHR needed co-transfection of RTP1 with GFP-TRPC2 to successfully reverse 
the effects. Co-transfection of RTP1 with GFP-TRPC2 had no additional beneficial effect on 
acute calcium signaling. The effect of RTP1 is therefore presumably on more long-term 
signaling. The immature form of Tg was decreased when RTP1 and GFP-TRPC2 were co-
transfected to shTRPC2 cells. Taken together, the results seen with knockdown of TRPC2 are 
reversible, although RTP1 is required in concert with TRPC2 to restore downstream signaling. 
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6 CONCLUSIONS 
 
The following conclusions are made based on the results obtained in the three original 
publications presented herein. 
 
1) When overexpressed in HEK-293 cells, TRPC3 does not to any greater extent influence 
calcium entry. In contrast, overexpression of TRPC3 reduces the intracellular calcium 
stores, which reduces IP3-mediated calcium responses. Our results indicate that 
TRPC3 is partly located in intracellular membranes, where it might form functional 
calcium release channels thus reducing the calcium stores of the ER. 
 
2) Caly A-evoked calcium entry is mediated by TRPC2 in FRTL-5 cells. 
 
3) The caly A-mediated calcium entry is regulated by SK1. Both decreasing the amount 
of the substrate, sphingosine, and increasing the amount of the product, S1P, is 
crucial for the calcium entry. Sphingosine potently blocks the influx of calcium, while 
S1P is transported out of the cells and activates S1P2-receptors in an autocrine 
manner. The S1P2-receptors activate PLC, which subsequently produces DAG that 
stimulates calcium entry. Caly A increases the net S1P concentration in the cells by a 
mechanism that is not dependent on SK activity. 
 
4) TRPC2 is expressed in rat thyroid gland and TRPC2 is the only TRPC channel expressed 
in FRTL-5 cells derived from rat thyroid. TRPC2 is activated downstream of GPCR-
activation and mediates calcium entry in FRTL-5 cells. 
 
5) The activity of calcium-inhibited ACs, presumably AC5 and AC6, is increased in cells 
where TRPC2 expression is reduced by shRNA (shTRPC2). The increased cAMP in 
these cells results in activation of Rap1 and the MEK/ERK1/2 pathway. The expression 
of the TSHR is increased due to activation of the ERK1/2 pathway. 
 
6) Glycosylation of Tg is perturbed in shTRPC2 cells, which leads to retention of 
immature Tg in the ER. Due to this, less Tg is secreted from shTRPC2 cells compared 
to FRTL-5 cells with intact TRPC2 function.   
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